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ABSTRACT 
In schizophrenia, decreased brain volume and altered cortical thinning (especially in the 
frontal and temporal areas), as well as white matter deficits are described at the first-episode. 
The relationship between these brain measures and clinical symptoms, whether there is 
progression, and the extent to which antipsychotic medication contribute to or mitigate those 
changes remains unclear. The aim of this PhD was to examine cortical thickness, brain 
volume (cortical, subcortical, white matter) and diffusion tensor imaging data, looking at the 
relationship between these brain measures and clinical variables in the first year of 
schizophrenia treatment.   
This PhD focused on the MRI subcomponent of a larger prospective longitudinal study in 
first-episode schizophrenia (FES) patients treated with flupenthixol decanoate medication. 
The thesis integrates the findings of five journal manuscripts that each focused on a clinically 
relevant neuroimaging question that emerged as we assessed patients in the parent study, 
namely insight, childhood trauma, neuroimaging predictors of symptom expression, and 
antipsychotic related brain changes.   
In our first manuscript, baseline fractional anisotropy (FA) in a number of white matter tracts 
predicted poorer total insight in 89 FES patients, with a predilection for tracts associated with 
cortical midline structures. In our second manuscript, the ‘symptom misattribution’ domain of 
clinical insight was associated with significantly thinner left anterior cingulate and left rostral 
middle frontal cortices. Our studies address a need for research in larger samples in FES to 
better understand the neurobiology of insight in schizophrenia.  In our third manuscript, 
baseline FA deficits in cortico-limbic circuitry was associated with childhood trauma in 53 
FES patients compared to 51 controls, and there were differential effects of childhood 
emotional neglect (increased FA) and sexual abuse (decreased FA) on white matter in 
patients. To our knowledge, at the time of manuscript submission for publication, this was the 
first study examining the relationship between childhood trauma, FA and FES.  
For our fourth manuscript, baseline brain measures in 54 FES patients were differentially 
associated with state and trait symptom expression over 12 months, with global gray matter 
significantly associated with sensory integration and verbal learning trait scores, cortical 
volume with verbal learning trait scores, cortical thickness with social and occupational 
functioning trait scores, and white matter volume with motor coordination state scores. Of 
potential relevance to patient care is that these neuroimaging deficits at initial presentation in 
FES may predict enduring trait deficits in cognition, functioning and neurological soft signs. 
For our final manuscript, total antipsychotic dose was a predictor of substantial cortical brain 
volume reductions over twelve months of treatment in 23 antipsychotic naïve patients 
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compared to 53 matched controls. Our finding of a significant relationship between 
antipsychotic dose and cortical volume reduction in this study strongly suggests causality. 
Future research directions stemming from this PhD include further exploration of our 
longitudinal data, strengthening our clinical assessments of insight and childhood trauma, 
connectomic analyses, a multi-modality neuroimaging approach, hippocampal subfield 
segmentation, and broadening our international collaborations.  
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OPSOMMING 
In skisofrenie word verminderde breinvolume en veranderde kortikale verdunning (veral in 
die frontale en temporale areas) sowel as witstof-tekorte reeds by eerste aanvang beskryf. 
Die verwantskap tussen hierdie brein afmetings en kliniese simptome, of daar voorsetting is 
en die mate waartoe antipsigotiese medikasie hierdie veranderinge vererger of versag is 
onduidelik. Die doelwit van hierdie PhD was om kortikale dikte, breinvolume (kortikaal 
subkortikaal, witstof) en “diffuse tensor” beeldingsdata te ondersoek deur te kyk na die 
verhouding tussen hierdie brein afmetings en kliniese veranderlikes gedurende die eerste 
jaar van skisofrenie behandeling. 
  
Hierdie PhD se fokus was die MRB sub-afdeling van ‘n omvattende prospektiewe 
longitudinale studie in eerste aanvangs skisofrenie (EAS) pasiënte behandel met flupenthixol 
dekanoaat medikasie. Die tesis integreer die bevindinge van vyf joernaal manuskripte wat 
elkeen gefokus het op ‘n klinies relevante neurobeeldingsvraagstuk soos na vore gekom 
tydens die assessering van pasiënte in die oorhoofse studie; naamlik insig, trauma tydens 
kinderjare, neurobeeldingsvoorspellers van simptoom uitdrukking, en antipsigotika-verwante 
breinveranderinge. 
  
In ons eerste manuskrip het basislyn fraksionele anisotropie (FA) in ‘n aantal witstoftrakte 
laer globale insig in 89 EAS pasiënte voorspel met ‘n voorkeur vir trakte geassosieer met 
midlyn kortikale strukture. In ons tweede manuskrip was die “symptom misattribution” domein 
van kliniese insig geassosieer met ‘n beduidend dunner linker singulaat en linker rostrale 
middel frontale kortises. Ons studies spreek tot die behoefte vir groter studiegroepe in EAP 
om sodoende die neurobiologie van insig in skisofrenie beter te verstaan.   
 
In ons derde manuskrip was basislyn FA tekorte in kortiko-limbiese bane geassosieer met 
trauma in die kinderjare in 53 EAS pasiënte in vergelyking met 51 kontroles. Daar was ook 
differensiele effekte op witstof vir verwaarlosing in die kinderjare (verhoogde FA) en seksuele 
misbruik (verminderde FA) in pasiënte. Toe die manuskrip vir publikasie voorgelê is, was dit, 
na die beste van ons wete, die eerste studie wat die verwantskap tussen trauma in die 
kinderjare, FA en EAP ondersoek het. 
  
Vir ons vierde manuskrip was basislyn brein afmetings in 54 pasiënte differensieël 
geassosieer met toestand en eienskap simptoom uitdrukking oor 12 maande, met globale 
grysstof beduidend geassosieer met sensoriese integrasie en verbale leer eienskap tellings, 
kortikale volume en verbale leer eienskap tellings; kortikale dikte met sosiale- en 
werksfunksionering eienskap tellings en witstof volume met motor koordinasie toestand 
tellings.. Dat hierdie neurobeeldingsuitvalle wat teenwoordig is met die eerste episode dalk 
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blywende eienskap uitvalle in kognisie, funksionering en neurologiese sagte tekens mag 
voorspel is potensieel van waarde vir pasiëntsorg. Vir ons laaste manuskrip het die totale 
antipsigotika dosis aansienlike kortikale breinvolume vermindering voorspel oor 12 maande 
van behandeling van 23 antipsigotika naïewe pasiënte in vergelyking met 53 
ooreenstemmende kontroles.Our finding of a significant relationship between antipsychotic 
dose and cortical volume reduction in this study strongly suggests causality. Ons bevinding 
in hierdie studie van ‘n beduidende verhouding tussen antipsigotika dosis en kortikale 
volume vermindering suggereer sterk oorsaaklikheid. 
  
Toekomstige navorsingsgeleenthede wat voortspruit uit hierdie PhD sluit in: verdere 
ondersoek van ons longitudinale data, geleenthede om kliniese assessering van insig en 
trauma in kinderjare te versterk; “connectomic” analises, multi-modale 
neurobeeldingsbenaderinge, hippokampale subveld segmentasie en die uitbreiding van ons 
internasionale samewerkings-ooreenkomste. 
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CHAPTER 1: INTRODUCTION 
CONTEXTUALISING GLOBALLY AND LOCALLY RELEVANT FIRST-
EPISODE SCHIZOPHRENIA NEUROIMAGING RESEARCH 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
2 
This chapter begins with an overview of select topics which serves to contextualise the thesis 
rather than provide a comprehensive review of magnetic resonance imaging findings in first-
episode schizophrenia. This overview is followed by the aims and objectives of the thesis 
after which I describe the parent study in which my PhD is nested. To conclude, I provide a 
brief summary of the subsequent chapters and describe how the included journal 
manuscripts serve as a coherent body of work.  
SCHIZOPHRENIA: BURDEN OF DISEASE  
Schizophrenia is a severe, disabling illness characterised by psychosis, apathy and 
withdrawal, and cognitive impairment, which result in deterioration in social and occupational 
functioning (van Os and Kapur, 2009). Schizophrenia affects approximately 0.3% to 0.7% of 
the population at some point in their life and contributes significantly to the global health 
burden because of its early onset, devastating effects and chronic course (WHO, 2011). The 
aetiology of schizophrenia remains poorly understood and neuroimaging techniques, such as 
magnetic resonance imaging (MRI), have enabled investigation of possible pathological 
processes involved in the illness.  
THE CONTRIBUTION OF NEUROIMAGING TO UNDERSTANDING SCHIZOPHRENIA  
Over 100 years ago Kraepelin theorized that damage to the cerebral cortex, in particular the 
prefrontal and temporal cortex, plays a fundamental role in the pathogenesis and progression 
of schizophrenia (Shenton et al. 2010). Interest in brain abnormalities was rekindled in 1976 
when the first computed tomography (CT) study described dilated lateral ventricles in 
schizophrenia (Johnstone et al. 1976). A considerable number of CT and MRI studies came 
after. The first MRI study in schizophrenia was published in 1986 (Andreasen et al. 1986) 
and although resolution in early MRI studies was poor relative to MRI scans of today, it still 
greatly surpassed that of CT scanning with regards to the ability to differentiate between gray 
and white tissue and to assess subtle changes in brain volume. In recent years, the cost of 
MRI has decreased, spatial resolution has increased, magnet strength has progressed and 
the entire brain can be scanned in a relatively short period of time.  MRI is currently the 
neuroimaging modality of choice in schizophrenia.  
 
Neuroimaging, particularly MRI, has extensively expanded our knowledge of schizophrenia 
although we are left with many important questions. What is the degree of pathology evident 
at illness onset? Are there evolving brain deficits over the early illness course? Do brain 
deficits predict therapeutic outcome? Addressing these questions could contribute to a better 
understanding of the core pathophysiology of schizophrenia and more effective intervention 
for the illness (Gong et al. 2015).  
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MAGNETIC RESONANCE IMAGING  
What is MRI? 
MRI is a medical scanning technique that, at an elemental level, uses a strong magnet and a 
radio transmitter and receiver to generate images. Hydrogen protons in the body behave 
somewhat like bar magnets spinning along their north-south poles with their axes randomly 
aligned. When a person is placed in an MRI scanner, strong magnetic field leads to the 
protons’ axes all lining up which creates a magnetic vector along the axis of the MRI 
scanner. When pulses of radio waves are added to the magnetic field, the magnetic vector is 
deflected. When the pulse is switched off, the magnetic vector relaxes back to a resting state 
and a radio wave signal is emitted. These radio signals are plotted to create an MR images. 
To distinguish protons from one another, MRI’s manipulate both the magnetic field and the 
pulse sequence of radio wave energy so that different tissue types (e.g. gray matter, white 
matter) emit slightly different radio signals in order to build a three-dimensional image 
(Berger 2002).  
Freesurfer and automated processing of MRI 
The use of automated post-processing computer software is a relatively recent way to 
classify and quantify brain tissue in neuroimaging studies. These software packages 
automatically remove non-brain tissue, align the brain to a common system and segment the 
brain into different tissue types based on MRI signal intensity (Ashburner and Friston 2000). 
An advantage of computerised image analyses is that a large number of images can be 
processed in a shorter period of time.  This is especially important since MRI costs and 
image acquisition times are decreasing and image datasets are growing. By reducing the risk 
of measurement bias inherent to humans tracing brain structures, computerised post-
processing also increases consistency and sensitivity of measurement (Morey et al. 2010). 
Freesurfer (http://surfer.nmr.mgh.harvard.edu/) is a widely used open source automated 
processing software package that was used for the measurement of brain volume and 
cortical thickness in this PhD study.  
Cortical thickness 
Cortical thickness is an indication of the size, density, and arrangement of neurons, neuroglia 
and nerve fibres (Narr et al. 2005), and abnormalities in cortical thickness may suggest 
fundamental neuropathological abnormalities in the intrinsic structure and integrity of cortical 
laminae (Kuperberg et al. 2003). Cortical thickness may be a more sensitive measure of 
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subtle gray matter abnormalities in schizophrenia than volumetric studies, particularly in the 
early phase of the disorder (Xiao et al. 2013). Cortical thickness studies in schizophrenia, 
particularly those examining for a relationship with clinical factors are few and results are 
inconsistent. This may in part be due to studies with relatively small sample sizes assessing 
multiple brain regions each with small effect sizes in the presence of large inter-individual 
differences. Also, potential confounding effects of age, and antipsychotic exposure in 
patients with chronic schizophrenia need to be taken into account.  
Diffusion Tensor Imaging (DTI) 
Brain connection irregularities within and between brain regions may constitute core 
pathology in schizophrenia (Wheeler and Voineskos 2014) and white matter forms the basis 
of this connectivity. The microstructural properties of white matter tracts are usually studied 
in vivo with DTI, an approach that provides a number of measures of white matter integrity, of 
which Fractional Anisotropy (FA) is probably the most commonly reported (Wheeler and 
Voineskos 2014). FA values are thought to reflect both myelination and organization of fibre 
tracts that form the basis of brain connections (DeRosse et al. 2014). A meta-analysis of DTI 
findings in first-episode schizophrenia reported reduced FA predominantly in the right deep 
frontal and left temporal lobes in patients compared to controls although results of individual 
studies are quite variable. This may be because FES changes are subtler than in chronic 
schizophrenia and may only manifest later in the disorder, possibly because of medication 
effects (Fitzsimmons et al. 2013), or because sample sizes in FES are frequently small and 
studies are heterogeneous from a methodological perspective.  
Baseline MRI findings in first-episode schizophrenia  
Brain structural abnormalities in schizophrenia are described at both the first-episode and in 
the chronic phase of the illness (Chan et al. 2011) and considerable evidence suggests that 
schizophrenia is a brain disease characterised by reductions in gray matter and white matter 
(Bora et al. 2011). A meta-analysis of brain volume in 8327 patients with schizophrenia 
including 771 medication naïve, recent onset patients found a small but significant decrease 
in intracranial volume in patients compare to controls and nearly twice as great a reduction in 
total brain volume. Total brain volume decrease was attributable to a decrease in gray matter 
(white matter volume decrease was similar to that of intracranial volume). Effect sizes of total 
brain volume and gray matter volume in medicated patients were 30% lower than in 
antipsychotic naïve patients and that of white matter volume was comparable. The authors 
argue that white matter volume reduction is present before antipsychotic treatment is started 
and progresses little while gray matter volume reduction worsens with illness duration and 
higher dose of antipsychotic treatment (Haijma et al. 2012).   
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Studies investigating cortical thickness are relatively few and findings are inconsistent. 
Findings of reduced thickness in bilateral dorsolateral prefrontal cortex thickness in first 
episode and chronic schizophrenia has been described (Wheeler et al. 2013). Negative 
results in a first-episode schizophrenia study have also been reported (Goghari et al. 2013), 
as have widespread differences in cortical thickness (including both thinning and thickening) 
in a large sample of antipsychotic naïve patients (n=128) compared to controls (n=128) (Xiao 
et al. 2013). Padmanabhan and colleagues found that positive symptoms in particular were 
correlated with gray matter volume and cortical thickness in frontal and temporal regions 
although the magnitude of correlations were low (Padmanabhan et al. 2014).  
 
Studies of white matter in first-episode schizophrenia indicate widespread abnormalities 
including the corpus callosum (Rotarska-Jagiela et al. 2008), fornix (Kuroki et al. 2006), 
cingulum (Kubicki et al. 2003), uncinate (Mandl et al. 2013) and inferior longitudinal 
fasciculus (Ashtari et al. 2007). Although there are inconsistencies in results (Melonakos et 
al. 2011), there is evidence for a predilection for frontal and temporal deep white matter 
(Ellison-Wright and Bullmore 2009). White matter changes may be linked to the development 
of schizophrenia and appear to be in keeping with the neurodevelopmental model of the 
illness (Sommer and Kahn 2014;Collin et al. 2013). On the other hand, volume changes and 
thinness of the cortex (particularly frontal and temporal) appear to be related to the illness 
itself and possibly associated with outcome and antipsychotic medication (Sommer and Kahn 
2014) which is more in keeping with the neuroprogressive (or neurodegenerative) model of 
the illness. Also, somewhat counter-intuitively, there is some evidence for increased regional 
gray matter volume (e.g anterior cingulate, orbitofrontal gyrus, thalamus (Ellison-Wright et al. 
2008;Szeszko et al. 1999)) as well as increased cortical thickness in the temporal lobe 
bilaterally prior to treatment onset (Xiao et al. 2013). This increase may be due to a deficit in 
normal pruning, or acute neuroinflammation, preapoptotic osmotic changes or hypertrophy 
(Gong et al. 2015;Xiao et al. 2013).    
 
Although studies have described correlations between regional brain volume deficits and 
positive and negative symptoms, the relationships between clinical symptoms and brain 
pathology has been, at best, fairly modest (Gong et al. 2015).  The limited success has in 
part been because a number of conceptual and methodological challenges undermine the 
efforts to link symptom severity with neurobiological correlates.  These challenges include 
the confounding effects of medication, small sample size, the use of different instruments to 
measure symptoms and the failure to distinguish state-trait effects (Mathalon and Ford 
2012).   
Stellenbosch University  https://scholar.sun.ac.za
 
 
6 
Neuroimaging predictors of outcome in first-episode schizophrenia 
The baseline MRI findings in schizophrenia described above offers some hope that these 
deficits may serve as potential biomarkers for treatment outcome. A review of eleven studies 
by Dazzan and colleagues found that reductions in medial temporal and prefrontal volumes 
and in the networks that connect them may be related to poor symptomatic and functional 
outcomes (Dazzan et al. 2015). The authors also noted that there are relatively few studies 
related to the topic and results are inconsistent with a large variability in findings.  
Longitudinal neuroimaging findings in first-episode schizophrenia 
There is growing evidence from longitudinal studies that global gray matter volume reduction 
in schizophrenia is progressive and is most pronounced in the early phase of the illness 
(Liberg et al. 2016;Pantelis et al. 2005). Progressive neocortical gray matter volume loss and 
ventricular enlargement seems to be particularly pronounced with a relative sparing of white 
matter volume (Nakamura et al. 2007). It has been suggested that while schizophrenia may 
arise from a neurodevelopmental diathesis, its pathophysiology may be progressive after the 
onset of the illness (Lieberman et al. 2005).  Decreased brain volume (Hulshoff Pol and Kahn 
2008) and altered cortical thinning (van Haren et al. 2008) especially in the frontal and 
temporal areas progress as the illness worsens. It remains unclear the extent to which 
clinical outcome and antipsychotic medication contributes to or mitigates these brain 
changes (Vita et al. 2015). 
 
Although schizophrenia patients with high levels of negative symptoms (Hulshoff Pol and 
Kahn 2008) and disorganization (Collin et al. 2012) exhibit more pronounced decreases of 
brain volume longitudinally, studies examining the relationship between symptomatology and 
progressive brain volume changes are limited and have yielded inconsistent findings. In 
general, most studies examining clinical parameters in relation to possible brain volume 
changes over time find no significant association (Sommer and Kahn 2014).  However, there 
is some evidence that longitudinal brain changes are related to outcome and, at least in part, 
to antipsychotic medication (Vita et al. 2015).  
AIMS  
The overall aim was to examine brain structure and white matter in a cohort of patients with 
first-episode schizophrenia, and to assess the relationship between these brain measures 
and multiple demographic, clinical, and cognitive variables.  
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OBJECTIVES 
The thesis focused on the following MRI brain measures: 
brain volume (cortical, subcortical, white matter), cortical thickness, fractional 
anisotropy. 
 
The objectives of the study addressed the overall aim by examining: 
1. The difference in baseline brain measures between first-episode schizophrenia 
patients and matched community controls. 
2. The relationship between brain measures and demographic, clinical and cognitive 
variables in patients experiencing a first-episode of illness. 
3. Whether baseline brain measures are predictive of clinical and cognitive outcome for 
schizophrenia at 12 months. 
4. Changes in brain measures over time after a first-episode of schizophrenia. 
 
OVERALL DESCRIPTION OF THE PROJECT 
Overview of parent study  
This PhD was a sub-study of a larger prospective longitudinal study investigating clinical, 
biological and functional aspects of outcome in first-episode schizophrenia.  
 
For inclusion in the parent study, patient participants had to be aged 16-45 years and 
experiencing a first-episode of schizophrenia, schizophreniform disorder, or schizoaffective 
disorder. First-episode patients were recruited from in- and out-patient services at Tygerberg 
Hospital and related community clinics. The control group was recruited from the same 
community as the patient group and matched for age, and sex. Patients and controls were 
excluded if they had a serious or unstable general medical condition, mental retardation, 
overt substance abuse and less than 7 completed years of schooling.  
 
Patients were excluded if they had lifetime exposure to > 4 weeks of antipsychotic 
medication or were previously treated with a long-acting depot antipsychotic. The parent 
study was registered on the South African National Clinical Trials Register 
(www.sanctr.gov.za/SAClinicalTrials/tabid/169/Default.aspx), trial number DOH-27-0710-
1957. The study was conducted according to the principles of the Declaration of Helsinki 
2008 (http://www.wma.net/en/20activities/10ethics/10helsinki/). After the study procedures 
were fully explained in accordance with the ethical guidelines of the Stellenbosch University 
Human Research Ethics Committee, participants provided written informed consent which 
encompassed all aspects of my PhD study. 
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Outline of the thesis 
My study focused specifically on the MRI component of the parent study. I examined cortical 
thickness, brain volume and white matter (diffusion tensor imaging) MRI data, looking at the 
relationship between these measures and clinical variables in the first year of treatment for 
schizophrenia. This thesis integrates the findings of five journal articles, three of which have 
been published (two with the PhD candidate as first author and one as second author), and 
two publications that are under review at international peer reviewed journals (both with the 
PhD candidate as first author).  
 
Of the 126 patients recruited into the parent study, the first 25 were excluded from the 
neuroimaging component because of an approval delay for scans. The number of 
participants in each journal article differs according to the research question and the 
available data for that question.  For example, Chapter 6 included patients who were 
antipsychotic naïve only, Chapter 5 did not include controls, childhood trauma data was not 
available for all participants (Chapter 4). Each journal article details the inclusion and 
exclusion criteria relevant to that research question.  
 
The coherence of this thesis is based on three themes that run through the included journal 
manuscripts. Firstly, under the guidance of my supervisors, for each first author manuscript I 
led the process of deciding on a research question, assisted with pre- and post-processing of 
scans, performed the statistical analysis, did clinical assessments of participants and 
controls, drafted, edited, finalized and submitted journal manuscripts for publication.  
 
Secondly, there was an opportunity with each journal article for myself and the schizophrenia 
neuroimaging team to develop skills in neuroimaging and statistical analysis. This includes 
skills training in DTI analysis for myself and other schizophrenia researchers (Chapter 2 and 
4 are the first DTI based articles published from our unit). We also learnt statistical 
techniques novel to our team, such as least angle regression (chapter 2), hierarchical 
regression (chapter 5) and whole brain analysis (chapter 4). 
 
And thirdly, each article fulfils at least two of my study objectives while being fundamentally 
clinically relevant at a local and global level.  My objectives for the PhD study were broad to 
provide the scope to address neuroimaging research questions that were relevant to the 
clinical needs of patients as they emerged in the parent study. Some of the clinical concerns 
that emerged as we assessed participants clinically included the high prevalence of 
childhood trauma in our sample (chapter 4), the challenge of treating a patient with impaired 
insight (chapter 2 and 3), the effects of uninterrupted medication administration that was 
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given in our parent study (chapter 6), and the difficulty predicting which patients will have 
enduring clinical symptoms (chapter 5). In this respect, each manuscript is linked by these 
central themes. 
 
Chapter 2 is a published journal article that examined for white matter fractional anisotropy 
differences between 89 first-episode schizophrenia patients and 98 community controls, and 
identified those differences associated with impaired insight in patients. At the time of 
publication, no other known study had examined the relationship between insight and white 
matter in first-episode schizophrenia, and findings from chronic schizophrenia were 
inconsistent. We used a machine learning algorithm to examine white matter regions across 
the entire brain as delineated by tract based spatial statistics (TBSS) for predictors of insight. 
 
Chapter 3 is a published journal article and extends the findings of Chapter 2. Symptom 
attribution involves the awareness of symptoms as well as the ability to relabel symptoms as 
pathological, which is thought to require a higher level of insight function (Andreasen et al. 
1986). In contrast to the widespread network of brain areas implicated in other insight 
domains (as described in Chapter 2), symptom attribution may more specifically relate to the 
frontal lobe. This paper uses a region of interest approach to examine the relationship 
between cortical thickness in 12 prefrontal regions and symptom attribution.  
 
Chapter 4 is an article undergoing peer review at an international journal.  This is the first 
known study to examine the relationship between childhood trauma and white matter in first 
episode schizophrenia. The article also reflects the evolution of clinical focus to childhood 
trauma within our larger schizophrenia research team.  
 
Chapter 5 is an article also undergoing peer review at an international journal. Here, we 
investigated for baseline brain volume predictors of trait (endpoint) and state (change) 
related clinical symptoms. Enduring clinical symptoms in patients with schizophrenia 
constitute a large proportion of the costs and burdens of the illness. There are currently no 
useful biomarkers for predicting which patients will have ongoing clinical symptoms and 
results from other studies are inconclusive.  
 
Chapter 6 is a published journal article which I second authored. Brain volume reduction is 
well documented in schizophrenia (Haijma et al. 2012) and longer-term studies provide 
evidence that these reductions are progressive (Vita et al. 2015). In this article, we examined 
for changes in cerebral gray and white matter volume over the first year of treatment in a 
subset of antipsychotic naïve patients. We compared brain volume in these patients to that of 
Stellenbosch University  https://scholar.sun.ac.za
 
 
10 
matched community controls and investigated whether brain changes in patients were 
associated with treatment and outcome.   
 
The concluding chapter (7) seeks to integrate the results of each journal article and provides 
a narrative synthesis of the results and summary of contributions in the context of the study 
objectives. This chapter also presents a set of concluding recommendations and suggestions 
for future research.  
 
I have included the published version of the journal articles if available (Chapters 2, 3 and 6).  
Chapters 4 and 5 are undergoing peer review and are formatted in keeping with the 
requirements of the respective journals. However, for uniformity I have formatted the 
references of all unpublished chapters in the same style (Chapter 1, 4, 5, 7). 
 
 
Manuscripts Publication 
status 
Number of 
participants 
Imaging 
modality 
Objectives 
addressed 
Chapter 2:  
Insight and white matter 
fractional anisotropy in first-
episode schizophrenia 
Published 
First Author 
 
89 Patients 
98 Controls 
DTI 1,2 
Chapter 3:   
Symptom attribution and 
frontal cortical thickness in 
first-episode schizophrenia 
Published 
First Author 
 
92 Patients 
93 Controls 
Cortical 
thickness 
1,2 
Chapter 4:  
Childhood trauma associated 
white matter abnormalities in 
first-episode schizophrenia 
Under 
review 
First Author  
 
53 Patients 
51 Controls  
DTI  1,2 
Chapter 5:  
Associations between global 
brain measures and state- and 
trait-related symptom 
expression of schizophrenia 
Under 
review  
First Author 
 
54 Patients  Brain volume, 
cortical 
thickness 
2,3 
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Chapter 6:  
Brain volume changes over the 
first year of treatment in 
schizophrenia: relationships to 
antipsychotic treatment 
Published, 
Second 
Author 
 
23 Patients  
54 Controls  
Brain volume 3,4  
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Supplementary Table 1: Fractional anisotropy (FA) differences between patient and healthy 
control groups after correction for multiple comparisons  
Fibre tract 
Right hemisphere  Left hemisphere 
Mean 
differe
nce 
95% CI p-value Mean 
differe
nce 
96% CI p-
value 
Association fibres       
Cingulum  
 
-0.021 
 
-0.033 to -0.010 
 
<0.001 
 
-0.011 -0.018 to -0.003 0.004 
Cingulum hpc 
 
-0.007 
 
-0.015 to 0.001 
 
0.058 
 
-0.015 -0.026 to -0.003  
0.017 
Sup Long Fasc  
 
-0.001 
 
 
-0.014 to 0.012 
 
0.882 
 
-0.009 -0.019 to 0.002  
0.11 
Sup Fronto-Occipital 
Fasc 
-0.007 
 
-0.016 to 0.001 
 
0.069 -0.017 0.027 to -0.006 0.104 
  Uncinate fasc 
-0.014 -0.031 to 0.002 0.087 -0.017 -0.029 to -0.005 0.003 
 
Sagittal stratum  
 
 
-0.017 
 
 
-0.028 to -0.006 
 
0.003 -0.017 -0.028 to -0.006 0.002 
 
External capsule 
 
 
-0.019 
 
 
-0.030 to -0.009 
 
<0.001 -0.021 -0.035 to -0.007  
0.004 
 
Fornix -0.013 -0.02 to -0.03    0.031 
Stria terminalis 
 
 
-0.013 
 
 
-0.026 to 0.001 
 
0.07 
 
0.001 -0.011 to 0.011  
0.94 
Commisural fibres       
Corpus callosum 
genu 
-0.021 -0.032 to -0.010 <0.001  NA 
 
Corpus callosum 
body 
-0.022 -0.033 to -0.012 <0.001  NA 
 
Corpus callosum 
splenium 
-0.012 -0.023 to -0.001 0.032  NA 
 
Tapetum  
-0.016 
 
-0.027 to -0.005 0.003 -0.011 -0.022 to 0.001 0.031 
Afferent projection 
fibres 
      
Sup cerebellar ped -0.010 -0.017 to -0.002 0.007 -0.012 -0.022 to -0.002 0.015 
Middle cerebellar 
ped 
 NS  -0.016 -0.025 to -0.006 0.001 
Pontine crossing 
tract: 
      
Inf cerebellar ped  
-0.010  
 
-0.017 to -0.003 
0.007 -0.014 -0.024 to -0.004 0.015 
Int capsule: ant limb 
-0.009 
 
-0.019 to -0.001 
 
0.047 
 
-0.011 -0.019 to -0.004 0.002 
Int capsule: post limb  
 
-0.012 -0.020 to -0.005 0.002 -0.012 -0.020 to -0.004 0.004 
Int capsule: 
retrolenticular 
-0.013 -0.021 to -0.004 0.005 -0.012 -0.022 to -0.002 0.002 
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P-value adjusted for multiple comparison: p=0.03 
 
 
 
 
  
Post thalamic radiation 
-0.123 
 
-0.243 to 0.000 
 
0.045 -0.017 -0.030 to -0.004 0.009 
 
Medial lemniscus 
-0.012 -0.021 to -0.003 
 
0.009 0.015 -0.025 to -0.006 0.002 
Efferent projection 
fibres 
      
Ant corona radiata:  
 
-0.017 
 
-0.028 to -0.006 
 
0.003 -0.016 -0.028 to -0.006 0.002 
Sup corona radiata 
-0.011 
 
-0.022 to -0.001 
 
0.029 -0.011 -0.020 to -0.001 0.024 
 
Post corona radiata 
 
-0.006 
 
-0.012 to 0.000 
 
0.051 -0.007 -0.132 to -0.001 0.032 
Cerebral peduncle 
-0.014 
 
-0.023 to -0.004 
 
0.007 -0.013 -0.023 to -0.004 0.006 
Corticospinal tract 
-0.013 
 
-0.023 to -0.004 
 
0.0008 -0.014 -0.023 to -0.006 0.001 
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CHAPTER 3: 
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FIRST-EPISODE SCHIZOPHRENIA 
 
Published article: 
Asmal, L., du Plessis, S., Vink, M., Chiliza, B., Kilian, S., Emsley, R. (2016). 
Symptom attribution and frontal cortical thickness in first-episode schizophrenia. 
Early Intervention in Psychiatry, 1, 1-8. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
27 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
28 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
29 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
30   
Stellenbosch University  https://scholar.sun.ac.za
 
 
31 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
32 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
33 
 
  
Stellenbosch University  https://scholar.sun.ac.za
 
 
34 
Supplementary table 1: 
Frontal ROI’s cortical thickness differences between FES patients and controls (critical 
threshold p=0.01, after correction for multiple comparisons) 
 
Frontal region of interest FES (n=92) HC (n=93) Relative 
difference 
(%) 
p-value 
Mean SD Mean  SD 
Left hemisphere        
Rostral middle frontal  2.46 0.02 2.52 0.19 2.38 0.05 
Caudal middle frontal 2.61 0.21 2.69 0.22 2.97 0.02 
Rostral anterior cingulate 2.92 0.32 2.91 0.31 -0.34 0.71 
Caudal anterior cingulate 2.71 0.25 2.74 0.27 1.09 0.40 
Lateral orbitofrontal  2.60 0.25 2.65 0.23 1.88 0.15 
Medial orbitofrontal  2.51 0.22 2.59 0.22 3.08 <0.01* 
Parsopercularis 2.60 0.25 2.68 0.25 2.98 0.02 
Parsorbitalis 2.65 0.35 2.68 0.32 1.12 0.58 
Parstriangularis 2.52 0.23 2.59 0.24 2.70 0.04 
Precentral 2.39 0.22 2.43 0.21 1.64 0.20 
Superior frontal  2.90 0.24 3.00 0.22 3.33 <0.01* 
Frontal pole 2.79 0.35 2.94 0.38 5.10 <0.01* 
Right hemisphere        
Rostral middle frontal  2.44 0.20 2.54 0.21 3.93 <0.01* 
Caudal middle frontal 2.60 0.23 2.67 0.24 2.62 0.04 
Rostral anterior cingulate 2.91 0.03 2.89 0.03 -0.69 0.66 
Caudal anterior cingulate 2.61 0.24 2.61 0.23 0.00 0.98 
Lateral orbitofrontal  2.61 0.24 2.70 0.26 3.33 0.01* 
Medial orbitofrontal  2.50 0.25 2.57 0.21 2.72 .005 
Parsopercularis 2.69 0.27 2.74 0.25 1.82 0.25 
Parsorbitalis 2.69 0.30 2.78 0.33 3.23 0.05 
Parstriangularis 2.58 0.24 2.66 0.25 3.00 0.02 
Precentral 2.38 0.23 2.41 0.21 1.24 0.29 
Superior frontal  2.86 0.22 2.97 0.22 3.70 <0.01* 
Frontal pole 2.76 0.28 2.88 0.42 4.17 0.04 
 
Relative difference (RD) is the percentage difference between cortical thickness in HC and 
FES patients and is calculated as follows: RD = [(meanHC-meanFES)/meanHC] X 100%  
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Abstract 
 
Schizophrenia is associated with brain connection irregularities within and between brain 
regions. Childhood trauma increases the risk of schizophrenia suggesting that the 
relationships between childhood trauma and brain connectivity requires further investigation. 
Here, we examine the relationship between childhood trauma (as measured by the 
Childhood Trauma Questionnaire) and fractional anisotropy (FA) in 53 minimally treated first-
episode schizophrenia patients and 51 community matched controls. Patients who 
experienced high levels of trauma had significantly lower FA in the inferior longitudinal 
fasciculus (ILF), superior longitudinal fasciculus (SLF), and inferior fronto-occipital fasciculus 
(IFOF) compared to controls who experienced high levels of childhood trauma. A history of 
childhood sexual abuse in patients was associated with lower FA in the IFOF, ILF, SLF and 
forceps major compared to patients without a history of sexual abuse. However, patients who 
had experienced childhood emotional neglect had higher FA in the right SLF compared to 
patients with low levels of emotional neglect. Our findings highlight altered cortico-limbic 
circuitry in first-episode schizophrenia patients compared to controls and differential effects 
of childhood emotional neglect and sexual abuse on white matter in patients. Although stress 
related WM pathways appear to be involved in both schizophrenia and otherwise healthy 
controls previously exposed to childhood trauma, the pattern of disruption of WM integrity in 
FES patients appears to be distinct.   
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1. Introduction 
There is a well-established link between childhood trauma and schizophrenia. A history of 
childhood trauma both increases the risk of developing psychosis,1 and is associated with 
greater co-morbidity,2  more cognitive impairment3 and persistence of symptoms over time.4 
Childhood trauma denotes a range of possible severe adverse experiences, including sexual, 
physical and emotional abuse, and physical and emotional neglect.5  One possible 
explanation for the association is that childhood is a sensitive developmental period and 
childhood trauma, through psychological or biological mechanisms, interferes with normal 
neurodevelopment, thereby establishing a biological vulnerability in affected individuals.6  
 
Indeed, adults with histories of childhood maltreatment have lower grey matter volumes in 
the anterior cingulate, prefrontal cortex, corpus callosum and hippocampus, higher amygdala 
reactivity to emotional faces and diminished striatal response to anticipated rewards than 
non-maltreated comparison subjects (for review see Teicher and Samson, 2016).7  Although 
the biological mechanisms that underlie these associations remain unclear, the evidence to 
date suggests that a history of childhood maltreatment is associated with disruption of the 
development and functioning of the HPA axis and may sensitise neurobiological systems 
implicated in stress adaptation and response thereby shaping neural structure and 
functioning.8–10 Childhood adversity may have a broad impact on neurodevelopment via a 
cascade of stress-mediated effects on hormones and neurotransmitters that shape 
neurogenesis, synaptic overproduction, pruning, and myelination during sensitive periods in 
genetically susceptible individuals, affecting stress-vulnerable brain regions such as the 
hippocampus, amygdala, neocortex, and white matter tracts.7,11  Among these, white matter 
abnormalities in healthy participants who experienced childhood trauma complement brain 
morphological studies. 
 
The microstructural properties of white matter tracts are usually studied in vivo with diffusion 
tensor imaging (DTI), an approach that provides a number of measures of white matter 
integrity, of which Fractional Anisotropy (FA) is probably the most commonly reported.12 FA 
values are thought to reflect both myelination and organization of fibre tracts that form the basis 
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of brain connections.13 A history of childhood trauma has been associated with white matter 
abnormalities in otherwise healthy participants, with a prediliction for the corpus callosum and 
cortico-limbic tracts.14  
 
Psychiatrically healthy adults with a history of childhood trauma have shown reduced FA in 
the corpus callosum, corona radiata, cingulum hippocampus, inferior fronto-occipital 
fasciculus, superior longitudinal fasciculus and uncinate fasciculus.14  Decreased FA in 
frontal and temporal white matter regions, including in the uncinate fasciculus, superior 
longitudinal fasciculus, and arcuate fasciculus, has been described in children with a history 
of early social deprivation.15 Adolescents who had experienced early childhood neglect 
showed lower FA values in the inferior fronto-occipital fasciculus, inferior longitudinal 
fasciculus, corticospinal tract, cingulum, anterior corona radiata as well as greater FA in 
anterior thalamic radiation and forceps minor compared with comparison adolescents who 
had not experienced neglect.16  
 
Considering the role of childhood trauma in increasing the risk of schizophrenia, the 
relationships between childhood trauma and brain connectivity in schizophrenia are of 
interest. Schizophrenia has been characterised as a disorder of brain connectivity,17–20 and 
several studies have demonstrated a disruption in the trajectory of white matter (WM) 
development in psychotic and clinical high risk samples.21–23 There is also growing evidence 
that childhood and adolescence are sensitive stress exposure periods when structures and 
pathways impacted by trauma are most vulnerable resulting in an alteration in trajectories of 
brain development.7,11  
 
To our knowledge, there is only one known neuroimaging study that has examined the 
integrity of white matter tracts in people with schizophrenia who have experienced childhood 
trauma.24 In a cohort of 83 patients with chronic schizophrenia, Poletti et al reported an 
association between an adverse early familial environment and reduced FA in the corpus 
callosum, left cingulum, left corona radiata, bilateral superior longitudinal fasciculus and left 
anterior thalamic radiation. Although these findings suggest the presence of a set of brain 
alterations common to both schizophrenia patients and non-clinical samples who have 
experienced childhood adversity, the lack of control group, the long illness duration and 
medication exposure limit the generalizability of these findings. Furthermore, the study used 
the Risky Family Questionnaire total score as a single measure of familial conflict, neglect 
and abuse and did not differentiate between trauma types, which may have differential 
effects. For example a history of childhood abuse is more pronounced for persistent positive 
symptoms, while neglect is associated with more general psychopathology.25,26 There is also 
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some evidence that there may be a greater association between psychosis and physical 
abuse than with other adverse childhood experiences.27  
 
This study examined whether DTI measures of WM tracts are associated with childhood 
trauma in first episode schizophrenia (FES). We used tract based spatial statistics (TBSS) to 
examine the relationship between childhood trauma and fractional anisotropy in FES patients 
(n=54) and healthy controls (n=51) recruited from the same geographical areas. Firstly, we 
hypothesized that childhood trauma related FA abnormalities would have a predilection for 
stress sensitive cortico-limbic tracts and the corpus callosum in patients and in controls. Next 
we hypothesized that these abnormalities would be greater in patients who experienced 
childhood trauma than in controls who experienced childhood trauma. Finally, we performed 
an exploratory analysis examining whether trauma subtypes had differential effects on white 
matter connectivity in patients.  
2. Methods 
2.1 Participants 
The sample comprised 77 minimally treated first-episode schizophrenia patients and 51 
matched controls as part of a study examining clinical, biological and functional outcome of 
FES in Cape Town, South Africa. Patients were recruited from inpatient services at 
Tygerberg and Stikland Hospital, and related community clinics in Cape Town, South Africa. 
For inclusion in the study, patients had to be aged 16 to 45 years, and experiencing a first 
psychotic episode meeting Diagnostic and Statistical Manual of Mental Diseases, Fourth 
Edition, Text Revisions (DSM-IV TR) diagnostic criteria for schizophrenia, schizophreniform 
or schizoaffective disorder based on the Structured Clinical Interview for DSM-IV (SCID) – 
Patient Edition.28 The healthy control group was matched for age, sex, ethnicity and level of 
education (Table 1), and had no DSM-IV axis I or II disorder as determined by the by SCID-
Non-Patient Edition interviews. Healthy controls were neighbourhood contacts of the families 
of the patients with FES and advertisements were placed in community centers in the same 
catchment area as the patients. Patients and controls were excluded if they had a serious or 
unstable general medical condition, mental retardation, current substance abuse (as 
confirmed by history taking of use in the past month or a positive urine drug screen), and less 
than 7 completed years of schooling. Patients and caregivers were interviewed to 
corroborate patient histories. Patients were excluded if they had a lifetime exposure to > 4 
weeks of antipsychotic medication or were previously treated with a long-acting depot 
antipsychotic. Each patient was carefully screened with a thorough physical examination and 
review of the medical history, ECG, urine toxicology screen and structured assessment of 
symptoms to verify that inclusion criteria were met. Duration of untreated psychosis was 
estimated from the onset of continuous positive psychotic symptoms to initiation of adequate 
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treatment. Adequate treatment was defined as the start of structured treatment with 
antipsychotic medication. Controls were excluded if they had a first degree relative with a 
psychotic disorder. Patients and controls were compensated for transport costs incurred 
during their participation in the study, but did not receive any other financial reward.  
 
This study was conducted according to the principles of the Declaration of Helsinki 2008 
(http://www.wma.net/en/20activities/10ethics/10helsinki/). After the study procedures were 
fully explained in accordance with the ethical guidelines of the institutional review board, 
participants provided written informed consent. The parent study was registered on the South 
African National Clinical Trials Register 
(www.sanctr.gov.za/SAClinicalTrials/tabid/169/Default.aspx), trial number DOH-27-0710-
1957.  
 
 
2.2 Clinical rating scales 
Diagnosis was assessed with the Structured Clinical Interview for DSM-IV [SCID].28 Severity 
of psychotic symptoms was assessed using the complete Positive and Negative Syndrome 
Scale (PANSS).29 Duration of untreated psychosis (DUP) was estimated from the onset of 
continuous positive psychotic symptoms to initiation of adequate treatment. Diagnosis and 
clinical assessment was determined by trained physicians, and inter-rater reliability testing 
was conducted periodically for the PANSS (intraclass correlation 0.7 or higher).  
 
Participants and controls were assessed with the Childhood Trauma Questionnaire (CTQ) 
short form, a self-administered inventory that has demonstrated reliable and valid 
retrospective assessment of child abuse and neglect.30 The instrument has 28 Likert-type 
items (25 clinical symptom items and 3 validity items to identify underreporting), and 5 
subscales (sexual abuse, physical abuse, emotional abuse, physical neglect and emotional 
neglect). Subscale scores range from 5-25 and the scale also yields a total score which is 
the sum of the 5 subscales ranging from 25-125.30 We included subscale and total scores in 
the analyses. Of the 77 first-episode schizophrenia patients who completed the childhood 
trauma questionnaire, 16 were excluded from the neuroimaging component because we 
applied for ethics approval for the MRI component once recruitment of patients in the parent 
study had already begun. A further 2 patients were lost because of scan error, 2 were 
excluded because of motion artefacts and 4 were unable to be scanned because of 
claustrophobia. Of the 52 controls, 1 was excluded due to scan error. 
 
2.3 Image acquisition 
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We acquired diffusion-weighted images (DWIs) on a 3.0 T Siemens Allegra MRI scanner 
(Erlangen), Germany with the following parameters: field of view= 220m, spatial resolution 
1.8X1.8X1.8mm3, repetition time= 8800ms, echo time 88ms, 65 slices, no distance factor 
with twofold GRAPPA acceleration.  The gradients were applied in 30 directions with 
b=1000s/mm 2 and a single unweighted volume (b=0s/mm2) were also acquired. The 
sequence was repeated three times.  
2.4 Image pre-processing 
 
The DWIs were pre-processed using the Functional MRI of the Brain (FMRIB) Software 
Library (FSL) version 4.1.8 (www.fmrib.ox.ac.uk/fsl/)31  Raw DTI data were corrected for eddy 
current distortions and head motion, and the images were imported into Matlab.32 The three 
acquisitions were co-registered by using the first b=0 mm/s2 as the reference image. Outliers 
were determined by calculating the Z-value of the tensor estimates at the 25th and 
75th percentiles. Data points falling outside of more than 3 standard deviations were 
discarded. The acquisitions were then averaged and exported to the FSL for further 
processing. 
2.5 MRI analysis  
Using FSL’s Randomize tool, permutation-based inferences with Threshold-Free Cluster 
Enhancement (TFCE) were carried out for voxelwise analysis of FA data.33 Tract-based 
spatial statistics (TBSS) version 1.2 was used for voxelwise analysis of the preprocessed FA 
data. First, individual FA images were aligned to the FMRIB58_ FA standard-space image, 
using nonlinear registration. Next, the mean FA image was generated and thinned to create 
a mean FA skeleton, which represents the centers of all tracts common to the entire group. 
The mean FA skeleton was then thresholded at a FA value of ≥0.4, to exclude peripheral 
tracts and minimize partial voluming. Finally, each participant’s aligned FA images were 
projected onto the mean FA skeleton and the resulting data were fed into voxelwise 
permutation-based analysis. The resulting statistical maps were corrected for multiple 
comparisons across space (p < 0.05) and the JHU White Matter and Juelich Histological 
atlases were used to label clusters with significant FA alterations.  
2.6 Statistical analysis  
We used analysis of t-tests and chi square tests to compare age, gender, and education in 
patients and controls. The CTQ total and subscales were not normally distributed; therefore, 
we used a median-split approach to dichotomise scores into high/low severity of trauma. For 
our primary analyses, we performed whole brain analyses examining for overall FA 
differences between all FEP patients and controls and  compared FA between those who 
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had high levels of overall childhood trauma and those who had low levels. We thereafter 
performed post-hoc analyses comparing those who had high levels of trauma subtypes 
(sexual abuse, physical abuse, physical neglect, emotional neglect, emotional abuse) in 
various groups (within patients, between patients and controls and within controls). We 
assessed for between group (patient and control) interaction.  
3. Results 
3.1 Participant characteristics 
The clinical and demographic features are presented in Table 1. Age, gender, education and 
ethnicity were similar in patients and controls. Patients and controls had comparable CTQ  
total and subscale scores. In keeping with the high levels of community violence experienced 
by our cohort, there was no significant difference in the number of patients and controls with 
high levels of overall trauma and trauma subtypes (reported previously).34 FA values were 
significantly lower in FES patients compared to controls, as published in detail elsewhere.35  
 
3.2 Fractional anisotropy and childhood trauma in patients and controls 
3.2.1 Patients versus controls 
Total childhood trauma: Compared to matched controls who experienced high levels of CT, 
FES patients who experienced high levels of CT had significantly lower FA in a cluster 
centred in the left inferior longitudinal fasciculus (ILF), and superior longitudinal fasciculus 
(SLF), as well as a cluster in the right SLF and inferior fronto-occipital fasciculus (IFOF) 
(Table 2).  
Childhood trauma subtypes: There was no difference in FA between patients and controls 
who experienced high levels of childhood trauma for any of the subscales.  
 
3.2.2 Within patient group 
Total childhood trauma: There was no significant difference in FA in any tract between FES 
patients who experienced high levels of overall CT and FES patients who experienced low 
levels of CT. 
Childhood trauma subtypes: FES patients with high levels of childhood sexual abuse had 
lower FA in a cluster comprising the right IFOF, ILF, and forceps major compared to FES 
patients without a history of sexual abuse  (Table 3). On the other hand, FES patients with a 
history of high levels of childhood emotional neglect, had higher FA in the right SLF 
compared to FES patients with low levels of childhood emotional neglect (Table 4).   There 
were no significant differences in FA between FES patients who experienced high levels of 
physical neglect, physical abuse and emotional abuse compared to FES patients who 
experienced low levels. 
3.2.3 Within control group 
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Total childhood trauma: There was no significant difference in FA in any tract between 
controls who experienced high levels of overall CT and controls who experienced low levels 
of CT.  
Childhood trauma subtypes: There was no difference in FA between controls who 
experienced high levels and those controls who experienced low levels of childhood trauma 
in any of the subscales.  
 
4. Discussion 
 
Here, we investigated associations between white matter FA and childhood trauma in people 
with FES and in matched community controls. A key finding of our study is that FA of the ILF, 
SLF and IFOF is lower in childhood trauma exposed patients than in childhood trauma 
exposed controls.  These WM tracts have been shown to be compromised in 
schizophrenia36,37 and also known to be affected by childhood trauma7,14,38,39 which may point 
to biological markers of vulnerability and resilience to schizophrenia in childhood trauma 
exposed individuals.  
 
Our findings are in keeping with the only known previous study that examined DTI 
abnormalities related to childhood adversity in schizophrenia.24 The authors found that, in 83 
patients with chronic schizophrenia, higher exposure to harsh parenting was associated with 
lower FA in the bilateral SLF, left ILF, left cingulum, corpus callosum, left cingulum, left 
corona radiata, and left anterior thalamic radiation, although the lack of control group and 
illness chronicity limits the generalizability of these findings. 
The disconnection hypothesis proposes that, in schizophrenia, there is dysfunctional 
integration in distributed but circumscribed neuronal systems that leads to neuromodulatory 
failure, e.g. mesocorticolimbic dysconnectivity.40 The ILF, SLF and IFOF are important 
cortico-limbic tracts that are implicated in the pathophysiology of schizophrenia.41,42 The IFOF 
directly interconnects the occipital, posterior temporal and the orbito-frontal areas while the 
ILF connects similar brain areas indirectly, and is an important source of fibres afferent to the 
amygdala and hippocampus.43–45 The amygdala, hippocampus, prefrontal cortex and related 
pathways are integral to emotional response, fear modulation and memory. The involvement 
of the ILF, SLF and IFO in both childhood trauma and schizophrenia suggests that limbic 
circuitry may be particularly vulnerable to long-term consequences of childhood maltreatment 
in schizophrenia.  
 
A further important finding of our study is that FA was lower in FES patients with a history of 
childhood sexual abuse compared to FES patients without a history of sexual abuse. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
44 
Furthermore, FES patients who had experienced childhood emotional neglect had higher FA 
compared to patients without emotional neglect. These findings are consistent with the 
proposal that trauma types have differential effects on neurodevelopment and that childhood 
abuse and neglect lie along independent pathways to psychosis.25,26 McLaughlin and 
colleagues46 suggest that threat (e.g. sexual abuse) and deprivation (e.g. emotional neglect) 
are distinct dimensions of the environmental experience and may have distinct effects on 
neural development. 
 
FES patients with a history of sexual abuse had lower FA in clusters involving the IFOF, ILF, 
SLF and forceps major than patients without a history of sexual abuse. Whether sexual 
abuse exerts effects that can be differentiated from the effects of physical and emotional 
abuse remains to be determined. It could be speculated that sexual abuse is particularly 
pernicious and impactful on the developmental trajectory, resulting in specific neuroplastic 
adaptive changes. These adaptations, for example reduced synaptic density, may initially be 
protective in that it shields a child by gating sensory processing.47 However, later in life, 
these impaired neurobiological substrates may predispose to the development of disorders.47 
 
The finding of higher FA in the SLF in FES patients who experienced childhood emotional 
neglect compared to patients who did not experience emotional neglect is unanticipated, but  
does lend support to the theory that childhood abuse and neglect may lie on independent 
neurobiological pathways to psychosis. 25,34,48  
The superior longitudinal fasciculus (SLF) is the largest association tract, connecting the 
frontal lobe cortex to parietal, temporal and occipital lobe cortices.49 The seemingly 
counterintuitive finding of increased FA may in part be explained by the neurodevelopmental 
model of schizophrenia and the role of aberrant strengthening and pruning of synaptic 
connections associated with schizophrenia. Exposure to early stress may prompt adaptive 
brain development along alternative developmental pathways to enable survival in a stress 
filled world.11 This may be especially relevant to the experience of emotional neglect which is 
characteristically chronic in that there is a long-standing lack of parent-child attachment.50 It 
may be that a child develops adaptive responses to emotional neglect such as heightened 
sensitivity to interpersonal stress and avoidant coping mechanisms which may later be 
relevant factors implicated in the development of schizophrenia. Excessive pruning shown to 
occur in schizophrenia may lead to the preservation of exuberant connections as a result of 
childhood neglect which may thereafter contribute to symptom generating neural activity in 
people who develop schizophrenia. SLF is a late maturing tract and so may be differentially 
vulnerable to the effects of emotional neglect.  
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Strengths of our study include the inclusion of first-episode, minimally treated patients, which 
allowed us to largely eliminate the effect of treatment and illness chronicity as well as the 
inclusion of matched community controls who reported similar levels of childhood trauma 
exposure. We assessed the effect of different types of childhood trauma and used a well-
validated measurement of childhood trauma. Several limitations should be noted.  The CTQ 
is a retrospective self-rated instrument and nature of the trauma could not be explored in 
depth, nor does it assess the frequency of trauma and the age at which trauma first occurred. 
Further the CTQ does not assess other forms of childhood adversities such as witnessing 
domestic violence and bullying, the latter is hypothesized to be associated with psychosis.51 
We did not assess for the interaction effects of gender, ethnicity and substance use on whole 
brain analyses. Although we did not find a relationship between these variables and 
childhood trauma in patients and controls, these factors have been shown to be related to 
childhood trauma in other studies.50 
 
This study provides important preliminary data that increase our understanding of the 
relationship between childhood trauma and schizophrenia. Our findings highlight altered 
cortico-limbic circuitry in FES patients compared to community controls and differential 
effects of childhood emotional neglect and sexual abuse on white matter in FES patients. 
Although previous studies have found that stress related WM pathways appear to be 
involved in both chronic schizophrenia24 and otherwise healthy controls previously exposed 
to childhood trauma,14–16 the pattern of disruption of WM integrity in FES patients appears to 
be distinct.   
 
Future studies should focus on resilience factors to address why some individuals exposed 
to childhood trauma develop schizophrenia while others do not. It is also important to explore 
whether brain changes associated with childhood trauma in schizophrenia patients are 
correlated with clinical, cognitive and functional outcomes, while taking into account the 
possible confounding effects of age of onset of childhood trauma, cumulative trauma load, 
gender, age of onset and duration of psychosis, and treatment status. It would also be 
important to examine whether clinical symptoms in patient vary according to trauma subtypes 
and whether these differences influence DTI measurement. Finally, future research should 
consider critical periods during which the brain is particularly susceptible to both the impact 
of childhood trauma as well the development of schizophrenia. 
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Table 1: Demographic and clinical characteristics for first-episode schizophrenia and control 
groups 
Characteristic All participants Analysis 
FES (n=54) Controls (n=51) 
test 
statistic 
df p 
Male sex, n (%)  40(74) 35(67)   .07 
Age (mean, SD)  24.78 (6.98) 25.04 (6.85) t=.96 10
3 
.35 
Education (years) 9.9 (1.9) 10.3 (1.5) t=-1.93 10
3 
.11 
Ethnicity n(%)   x2=2.99  .22 
Black 0 (0) 6(15.79)    
Mixed race 15 (93.75) 29 (76.31)    
White 1 (6.25) 3 (7.89)    
CTQ, median [range]      
Emotional neglect 12[5-25] 9.5[5-24] z=-.821  .41 
Physical abuse 7[5-23] 7[5-25] z=-.194  .84 
Emotional abuse 9[5-22] 9[5-25] z=.413  .68 
Physical neglect 9[5-22] 8.5[5-17] z=-.88  .38 
Sexual abuse 5[5-25] 5[5-25] z=.390  .70 
Total score 46.5[25-92] 43[25-93] z=-.225  .82 
CTQ, High (%)*      
Emotional neglect 17(32.69) 14.26.92)   .64 
Physical abuse 20(38.46) 15(28.8)   .41 
Emotional abuse 15(28) 13(25.0)   .96 
Physical neglect 26(48.15) 22(42.31)   .65 
Sexual abuse 13(24.53) 14(26.92)   .85 
Total score 16(29.63) 13(25.00)   .70 
 FES only (n=54)    
 CTQ total high 
(n=16) 
CTQ total low 
(n=38) 
   
Age (mean, SD) 25.54 (7.68) 22.56 (5.42) t=1.68 52 .10 
Male sex, n(%) 13 (81.25) 27 (71.05) x2=0.61  .43 
Ethnicity n(%)   x2=2.99  .22 
Black 0 (0) 6(15.79)    
Mixed race 15 (93.75) 29 (76.31)    
White 1 (6.25) 3 (7.89)    
Education (years)    52  
Substance abuse 9(56.25) 15(39.47) x2=1.28  .26 
PANSS total score 94.2 (11.71) 92.32(14.53) t=-1.16 51 .28 
Antipsychotic naïve 8 (53.33) 18 (47.37) x2=.15  .70 
DUP  39.39(46.80) 29.15(32.35) t=-.91 51 .37 
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Table 2: Whole brain lower fractional anisotropy in FES patients with history of childhood 
trauma compared to FES matched controls with a history of childhood trauma.  
 
Brain 
region 
Tracts Hem Cluster 
size 
MNI coordinates of 
voxel of maximum 
significancea 
Probability 
x y z 
Cluster 1 Inferior longitudinal 
fasciculus, Sup long 
fasciculus (temporal part) 
L 34 125 77 99 .04 
Cluster 2 Sup long fasciculus 
(temporal part), Inferior 
fronto-occipital fasciculus 
R 214 59 87 86 .04 
 
Table 3: Whole brain lower fractional anisotropy in FES patients with history of childhood 
sexual abuse compared to FES patients without a history of sexual abuse 
 
Brain 
region 
Tracts Hem Cluster 
size 
MNI coordinates of voxel 
of maximum significancea 
Probability 
x y z 
Cluster 1 Inferior fronto-occipital, 
inferior longitudinal 
fasciculus, forceps major 
R 971 61 58 85 .006 
Cluster 2 Forceps major, inferior 
fronto-occipital fasciculus, 
inferior longitudinal 
fasciculus, superior 
longitudinal fasciculus 
L 2793 111 74 84 .007 
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Table 4: Whole brain higher fractional anisotropy in FES patients with history of childhood 
emotional neglect compared to FES patients without a history of emotional neglect  
 
Brain 
region 
Tracts Hem Cluster 
size 
MNI coordinates of 
voxel of maximum 
significancea 
Probabilit
y 
x y z 
Cluster 1 Superior longitudinal 
fasciculus 
R 4 63 84 115 .0001 
Cluster 2 Superior longitudinal 
fasciculus 
R 10 64 80 112 .0001 
Cluster 3 Superior longitudinal 
fasciculus 
R 21 53 93 100 .0001 
Cluster 4 Superior longitudinal 
fasciculus, Sup 
longitudinal fasc 
(temporal part) 
R 165 59 86 107 .001 
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Abstract 
The course of schizophrenia is characterised by episodes of psychotic symptoms (which may 
be largely state related) and enduring deficits of negative symptoms, cognition and 
functioning (which may be largely trait related).  Neuroimaging holds the promise that brain 
deficits may serve as a biomarker for illness detection and treatment outcome. We 
investigated the relationship between global brain measures and trait-related symptoms 
(endpoint scores), and global brain measures and state-related symptoms (change scores). 
We examined global cortical, subcortical and white matter volume, and global cortical 
thickness in 54 first-episode minimally treated schizophrenia patients at baseline. We 
performed clinical, cognitive, and neurological assessments at baseline and twelve-month 
follow-up. Baseline subcortical gray matter volume was significantly associated with sensory 
integration (0.02) and verbal learning (0.04) trait scores, cortical volume with verbal learning 
(0.04) trait scores, cortical thickness with social and occupational functioning (0.03) trait 
scores, and white matter volume with motor coordination (0.007) state scores. The 
differential associations between state and trait related symptoms and brain structure 
indicate that future studies assessing the neurobiological underpinnings of the illness should 
take care to differentiate between state and trait related manifestations. 
 
Keywords 
 
Cortical thickness/white matter volume/gray matter volume/subcortical volume/MRI 
 
Abstract word count: 187 
Manuscript word count: 3775 
Stellenbosch University  https://scholar.sun.ac.za
 
 
56 
1. Introduction 
The course of schizophrenia is typically characterised by episodes of psychosis 
superimposed on enduring deficits including negative symptoms and cognitive and 
psychosocial functional impairments (Andreasen et al. 2005). The degree to which symptoms 
can be categorised as being state or trait related, or mixed, has been a focus of attention as 
it would allow a better understanding of the neurobiology of the illness and the possibility to 
improve our ability to detect, treat and ultimately prevent the disorder. Typically, psychotic 
symptoms (delusions and hallucinations) may be largely state-related, whereas negative 
and cognitive symptoms may be largely trait-related. However, the distinction is not clear-cut 
as most-symptoms display both state-and trait-related features insofar as they improve with 
treatment, but persist to varying degrees as well. State markers reflect clinical 
manifestations of psychotic exacerbations whereas trait markers are typically enduring and 
relatively independent of state-related fluctuations in the individuals’ status. Trait markers 
could be brought about primarily by the expression of genes and are considered to be linked 
to the core abnormalities that play an antecedent and possibly causal role in the illness 
(Braff et al. 2006).  
Imaging studies have consistently demonstrated differences in brain morphology in people 
with schizophrenia compared with healthy volunteers. Brain structural alterations are present 
early in the illness and may predate symptom onset (Mechelli et al. 2011; Dazzan et al. 
2011). Abnormalities seen in first-episode schizophrenia patients when compared to controls 
are diffuse, comprising reductions of cortical and subcortical gray matter and white matter 
volumes (Haijma et al. 2012), as well as differences in cortical thickness (thinning and 
thickening) (Xiao et al. 2013). These neuroimaging findings offer some hope that brain 
deficits may serve as potential biomarkers for illness detection and treatment outcome.  
 
Efforts to understand the neurobiological basis of the symptom expression of schizophrenia 
by examining associations between symptoms and brain structure, have been largely 
unsuccessful (Mathalon and Ford 2012).  Although there is some indication from a recent 
systematic review that medial temporal and prefrontal cortical areas and related connections 
to subcortical regions may be related to outcome (Dazzan et al. 2015), there is considerable 
variability in findings. These inconsistencies are likely, at least in part, due to methodological 
shortcomings. For example, studies were frequently conducted in small patient samples, in 
different phases of illness (first-episode and multi-episode), and using cross-sectional 
designs.  Also, and of particular importance when considering state-and trait related 
manifestations of the illness, the clinical status of patients and duration of exposure to 
treatment has varied (Mathalon and Ford 2012). To accurately assess state-related features 
of illness, initial assessments need to be conducted in the acute, unmedicated state; and for 
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assessment of trait-related features, patients should have received the benefit of effective 
treatment for a sufficient period of time before symptoms are regarded as persistent. 
In this study, we carefully characterised the state and trait related components of the 
symptom expression of first-episode schizophrenia and determined their relationships with 
global cortical thickness and global brain volume (cortical volume, subcortical volume, white 
matter) measures. We defined symptom expression broadly to include measures of 
psychopathology, insight, functionality, neurological signs and cognition. We conducted 
baseline assessments in the acute, largely unmedicated state and then again following 
treatment with depot flupenthixol medication according to a standard protocol for 12 months. 
We hypothesised that global brain volume and cortical thickness measures would show 
stronger associations with trait-related (endpoint scores) rather than state-related symptoms 
(change from baseline to endpoint scores). Specifically, we hypothesised that endpoint 
negative, cognitive and neurological symptoms would have the more significant correlations 
with global brain volume and cortical thickness measures.  
 
2. Methods 
2.1 Overview 
This was a substudy of a longitudinal study assessing outcome in patients with a first-
episode of schizophrenia or related disorder who were treated for 12 months with the lowest 
effective dose of flupenthixol decanoate according to a standard protocol. We obtained ethics 
approval from the Human Research Ethics Committee of Stellenbosch University. The study 
was conducted according to the International Conference on Harmonization good clinical 
practice guidelines (Dixon 1999). The parent study was registered on the South African 
National Clinical Trials Register, trial number DOH-27-0710-1957, 
(www.sanctr.gov.za/SAClinicalTrials/tabid/169/Default.aspx). By selecting first-episode, 
minimally treated patients we minimised effects of illness chronicity and previous treatment. 
We conducted baseline assessments in the acute, largely unmedicated state, enabling us to 
capture the full range of symptoms prior to treatment effects. We treated patients according 
to a standard protocol with depot flupenthixol decanoate, thereby removing possible 
confounding differential effects of antipsychotics and covert non-adherence. We excluded 
patients who received treatment for less than 6 months, to ensure that endpoint assessments 
reflected an adequate treatment period for acute symptoms. We considered baseline 
assessments to represent a combination of state and trait related features. 
2.2 Participants 
Patients were recruited from psychiatric hospitals and clinics in Cape Town and surrounds 
between April 2007 and March 2011. They were all voluntary patients, and provided written, 
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informed consent to participate in the study. In the case of minors, we obtained consent from 
the legal guardian. Inclusion criteria for the parent study were men and women, aged 16–45 
years, experiencing a first psychotic episode meeting Diagnostic and Statistical Manual of 
Mental Diseases, Fourth Edition, Text Revisions (DSM-IV TR) (First 1994) diagnostic criteria 
for schizophrenia or schizophreniform disorder. Exclusion criteria were lifetime exposure to > 
4 weeks of antipsychotic medication, treatment with a long-acting depot antipsychotic, 
serious or unstable general medical condition, current substance abuse, an educational level 
<Grade 7 and contraindications for MRI scanning. For the present study, patients were 
included if they had a baseline structural MRI scan as well as clinical and cognitive data 
obtained at baseline and after at least six months of treatment. All patients were scanned 
within one week of recruitment into the study. 
2.3 Treatment  
Patients received oral flupenthixol 1–3 mg/day for 7 days, followed by flupenthixol decanoate 
injections 2-weekly for the study duration. Initiation dose was 10 mg 2-weekly, with 6-weekly 
increments of 10 mg 2-weekly IMI permitted, to a maximum of 30 mg 2-weekly IMI. 
Additional oral flupenthixol was permitted at the discretion of the investigator, as was 
lorazepam, anticholinergics, propranolol, antidepressants and medication for general medical 
conditions. No benzodiazepines, propranolol or anticholinergics were permitted in the 12 h 
prior to assessments.  
2.4 Clinical Evaluations 
Symptom expression was broadly defined and included measures of psychopathology 
(positive, negative, disorganised and excitement/hostility domains, depression), insight, 
functionality, neurological signs and cognition. Patients were assessed with the Structured 
Clinical Interview for DSM-IV (SCID) (First et al. 2012). Severity of psychopathology was 
assessed with the Positive and Negative Syndrome Scale (PANSS) (Kay et al. 1987). We 
used factor-analysis derived symptom domains for positive, negative, depression/anxiety, 
excitement/hostility and disorganised symptoms (Emsley et al. 2003). Depressive symptoms 
were assessed with the Calgary Depression Rating Scale for Schizophrenia (CDSS) 
(Addington et al. 1994). We administered the Clinical Global Impressions (CGI) Scale as an 
overall clinician determined summary measure (Guy 1976). Neurological soft signs were 
assessed with the Neurological Evaluation Scale (NES) (Buchanan and Heinrichs 1989). The 
NES is a structured clinical battery consisting of 26 items and provides three subscale scores 
reflecting dysfunction in sensory integration, motor coordination and motor sequencing as 
well as a NES total score. Insight was measured by means of the Birchwood Insight Scale 
(BIS) (Birchwood et al. 1994) which assesses three dimensions of insight: symptom 
awareness, illness awareness, and need for treatment, as well as providing a BIS total score. 
Functionality was assessed with the Social and Occupational Functioning Assessment Scale 
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(SOFAS) (Morosini et al. 2000). Investigators underwent training and inter-rater reliability 
(IRR) testing. The IRR was >0.75 for all scales.  
2.5 Cognitive evaluations 
Cognitive performance was assessed by the MATRICS (Measurement and Treatment 
Research to Improve Cognition in Schizophrenia) Cognitive Consensus Battery (MCCB), 
developed to measure cognitive functioning in schizophrenia. The MCCB measures seven 
cognitive domains (speed of processing; attention/vigilance; working memory; verbal 
learning; visual learning; reasoning and problem solving; and social cognition) and a 
composite score (Nuechterlein et al. 2008). The MCCB was administered by trained 
psychologists. 
2.6 State vs. trait assessments 
We assumed that clinical and cognitive scores in the acute state represent both state and 
trait components, while those in clinically stable patients represent trait components, and the 
degree of change from the acute state to stable state would represent state components. 
Therefore, for state-related clinical and cognitive variables we used change scores (endpoint-
baseline score). For trait-related clinical and cognitive variables we used endpoint scores, 
calculated by last observation carried forward. 
2.7 Imaging methods 
Patients underwent baseline scans before receiving any flupenthixol medication. We 
acquired high-resolution T1-weighted data on a 3T Siemens Allegra MRI scanner (Erlangen, 
Germany) with the following acquisition parameters: MPRAGE sequence, 2080 ms repetition 
time; 4.88 ms echo time, Field of view: 230 mm, 176 slices, 0.9 mm X 0.9 mm X 1 mm voxel 
size. Scans were screened for intracranial pathology and inspected for motion artefacts. 
Scans were processed and analyzed using Freesurfer stable release version 5.1. 
(http://surfer.nmr.mgh.harvard.edu/). Slices were resampled to a three-dimensional image 
with 1mm isotropic voxels. Non-uniform intensity normalization was performed and images 
were registered to the Montreal Neurological Institute (MNI) space. A second normalization 
step was performed with a different algorithm in which control points were automatically 
identified and normalized to a standard intensity value. Following an automated skull strip 
procedure, gross brain anatomy was delineated into cortical and subcortical labels. 
Reconstructions were performed with custom batching scripts, on the Centre for High 
Performance Computing (CHPC) Rosebank, Cape Town, Sun Intel Nehalem cluster 
(http://www.chpc.ac.za/). Skull stripping, Talairach transforms, atlas registration, spherical 
surface maps and parcellations were initialized with common information from the within-
subject template. All data were visually inspected for errors in Talairach transformation, skull 
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strip, final segmentations as well as the within subject-registrations. Any errors were 
corrected manually and re-inspected.  
2.8 Global brain measures  
We selected the following global measures of brain volume provided with Freesurfer 
(http://surfer.nmr.mgh.harvard.edu/): (1) Cortical volume – a surface-based volume 
calculation, comprising the volume inside the pial surface minus the volume inside the white 
surface minus tissue inside the ribbon that is not part of cortex. (2) Subcortical gray matter 
volume – a voxel count of the thalamus, caudate, hippocampus, amygdala, accumbens, 
ventral diencephalon and substantia nigra. (3) White matter volume – using surface-based 
volume computation for part of the calculation and voxel counts to subtract anything that is 
not white matter from the volume inside the white surface. We calculated global cortical 
thickness using a weighted composite measure of Freesurfer defined cortical thickness 
regions of interest.  
 
2.9 Statistical analyses 
We assessed the distribution of the data by inspection of histograms and normal probability 
plots. We conducted Pearson correlational coefficient analyses to investigate both state 
(change scores) and trait-related (endpoint scores) associations between baseline cortical 
thickness, cortical volume, white matter volume and subcortical gray matter volume and 
clinical and cognitive variables change and endpoint scores. Thereafter, we used hierarchical 
multiple regression to predict brain measures (cortical gray volume, subcortical gray volume, 
white matter volume, cortical thickness). For each of the brain measures, we ran separate 
models for change-related and state-related variables. First, an intracranial volume block was 
entered to allow the dependent brain volume variable to be adjusted for intracranial volume 
(this was not performed for cortical thickness). Second, a demographic block comprising 
patient age, education, and sex was entered. Third, a clinical block comprising scores on 
clinical assessments that correlated significantly with brain measures (correlation analyses in 
Supplementary table 1) was entered. Finally, a cognitive block comprising MCCB scores that 
significantly correlated with brain measures (correlation analyses in Supplementary table 2) 
was entered. The significance of each successive block’s contribution to validity was 
assessed with F tests. All tests were 2-tailed. 
 
3. Results 
3.1 Participant characteristics 
Demographic details, baseline and endpoint scores for the clinical and cognitive measures 
and brain volumetric measures for the 54 participants are provided in Table 1 and Table 2. 
Over the course of 12 months, PANSS scores (total and subscale), CDSS, GAF, CGI, 
SOFAS and MCCB cognitive scores improved (table 2). No significant improvement was 
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noted in neurological symptoms (as assessed by the NES), and insight (as measured by the 
BIS).  
3.2 Correlations  
Results for the correlation analyses between brain volume and cortical thickness measures 
and state-related (change) and trait-related (endpoint) scores are provided in Supplementary 
Table 1 and 2 respectively. Clinical and cognitive variables that correlated with brain volume 
and cortical thickness measures at uncorrected p<0.1 qualified for entry into the hierarchical 
regression models, summarised as follows: 
State-related (change) scores: White matter volume: processing speed ( r2.35, p=.01), visual 
learning (r2 .26, p=.07), social cognition (r2=.29, p=.04), total insight (r2=-.26, p=.06). Cortical 
volume: verbal learning (r2=.27, p=.06), working memory (r2 .44, p=.001), visual learning (r2 
=.23, p=.09), social cognition (r2=.34, p=.01). Subcortical volume: processing speed (r2=.37, 
p=.007), social cognition (r2=.35, p=.01), total insight (r2=-.33, p=.02). Cortical thickness: nil. 
Trait-related (endpoint) score: Cortical volume: sensory integration (r2=-.32, p=.02), working 
memory (r2=.31, p=.02), verbal learning (r2=.31, p=.02), illness awareness (r2=-.27, p=.05) 
White matter volume: sensory integration (r2=-.34, p=.01), processing speed (r2=.30, p=.03), 
working memory (r2=.38, p=.005), verbal learning (r2=.31, p=.02), visual learning (r2=.27, 
p=.05), reasoning and processing (r2=.24, p=.09), social cognition (r2=.37, p=.007), illness 
awareness (r2=-.29, p=.03). Subcortical volume: sensory integration (r2=-.24, p=.09), 
processing speed (r2=.28, p=.04), working memory (r2=.27, p=.05), verbal learning (r2=.32, 
p=.02), social cognition (r2=.40, p=.003), subcortical gray (r2=-.14, p=.31). Cortical thickness: 
social and occupational functioning scale (r2=0.27, p=.048). 
 
3.3 Regression models 
The results of the hierarchical regression analyses for predictors of cortical, white matter and 
subcortical gray matter volume are presented in table 3. As expected, intracranial volume 
and demographic variables accounted for a significant portion of variance in in cortical 
thickness and in cortical, subcortical and white matter volume.   
3.3.1 Clinical predictors of brain volume 
The block of state-related (change score) clinical predictors accounted for 8% of variance in 
white matter volume, while the block of trait-related (endpoint score) clinical predictors 
accounted for 7% of variance in subcortical volume. Within the clinical block of predictors, 
state-related (change) motor coordination scores as measured by the NES contributed 
significantly to the prediction of white matter volume (b = -.02, t = -2.80, P=0.007) and trait-
related (endpoint) sensory integration scores as measured by the NES contributed 
significantly to the prediction of subcortical gray matter volume (b = -.017, t = -2.32, P=0.02).  
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Trait social and occupational functioning significantly predicted cortical thickness (b= .003, t = 
2.21, P=0.03). 
3.3.2 Cognitive predictors of brain volume 
The block of trait-related (endpoint) cognitive scores accounted for 15% of variance in 
subcortical volume and 13% of variance in cortical volume. Within the block of cognitive 
predictors, trait-related verbal learning scores significantly predicted both cortical volume (b = 
.003, t = 2.04, P=0.04) and subcortical volume (b = .003, t = 2.01, P=0.04).  
 
4. Discussion 
In this study, in which the state and trait related components of the symptom expression of 
schizophrenia were carefully characterised, we found limited but differential associations 
between state and trait related symptoms and global brain measures on predictive modelling. 
Baseline subcortical gray matter volume was significantly associated with sensory integration 
and verbal learning trait scores, cortical volume with verbal learning trait scores, cortical 
thickness with social and occupational functioning trait scores, and white matter volume with 
motor coordination state scores.  
 
In our study, the trait-related cognitive domain of verbal learning was a significant predictor of 
both cortical and subcortical volume. Verbal learning and memory are considered the most 
prominent cognitive impairments observed in schizophrenia (Manglam and Das 2013) and 
have been associated with reduced gray matter volume in the cingulate cortex, 
juxtapositional lobule, right superior temporal gyrus, and precuneus (Rannikko et al. 2012). 
Our findings suggest that impaired verbal learning may be the cognitive domain that is 
particularly trait-related, and therefore presumably closest to the neurodevelopmental deficit 
underlying schizophrenia.  
 
We found that the trait-related component of sensory integration predicted cortical and 
subcortical gray matter volumes while the change-related component of motor coordination 
predicted white matter volume in the hierarchical regression analyses.  Neurological soft 
signs are not static but vary over the course of the disorder. They improve with antipsychotic 
treatment although not to the level observed in healthy controls. As such, they are regarded 
as having both state and trait characteristics, and are proposed to be useful in identifying 
subjects at risk to develop schizophrenia and to monitor disease progression (Bachmann et 
al. 2014). Neurological soft signs have also been related to structural brain deficits in 
schizophrenia. A meta-analysis of structural MRI studies reported their association with 
smaller precentral gyrus, cerebellum, inferior frontal gyrus and the thalamus (Zhao et al. 
2013). Our results suggest that the state and trait components of neurological soft signs may 
be differentially related to brain structure. Future studies could investigate the value of motor-
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coordination change scores in monitoring disease progression, as well as a region of interest 
approach to address the possibility that some symptoms are related to circumscribed rather 
than general brain structural deficits.  
 
We also found that social and occupational functioning trait scores significantly predicted 
global cortical thickness. Other first-episode schizophrenia studies have found that smaller 
baseline gray matter volume in the left orbitofrontal and frontopolar cortex (Kasparek et al. 
2009) as well as baseline volume of the left dorsolateral prefrontal cortex (Prasad et al. 2005) 
predicted poorer functioning at one year follow-up. These studies are limited by small sample 
sizes, and to our knowledge there are no other studies that have explored cortical thickness 
and functioning in schizophrenia. Specific cognitive and emotional functions regulated by the 
prefrontal lobe may be critical in outcome (Dazzan et al. 2015). Future studies should 
consider a region of interest analysis investigating the relationship between cortical thickness 
and functioning taking into account other potential mediators, such as depression and 
cognition.  
 
While several other significant associations were identified in the bivariate correlational 
analyses, most of these associations were lost when we controlled for age, gender, 
educational status and intracranial volume.  Most notably, none of the measures of 
psychopathology or insight were significantly associated with global brain volume or cortical 
thickness measures. Limited significant associations with symptom expression is not entirely 
unexpected, as studies to date investigating structural brain measures and symptom 
dimensions have reported mixed findings. Thus, positive symptoms have been associated 
with reductions in brain morphology in some studies (Barta et al. 1990; Flaum et al. 1995; 
Nestor et al. 2007; Lui et al. 2009; Nesvåg et al. 2009; Padmanabhan et al. 2014; Zhang et 
al. 2014; Walton et al. 2017a) but not in others (Turetsky et al. 1995; Fannon et al. 2000; 
Molina et al. 2003). Similarly, negative symptoms have been associated with brain 
morphology reductions in some studies (Nestor et al. 2007; Padmanabhan et al. 2014; 
Zhang et al. 2014;Turetsky et al. 1995; Molina et al. 2003; Baaré et al. 1999;Benoit et al. 
2012; Nenadic et al. 2015;Walton et al. 2017b) but not others (Barta et al. 1990; Flaum et al. 
1995;Lui et al. 2009; Fannon et al. 2000), and some studies even found less reduction in 
brain structures in patients with prominent negative symptoms compared to those without 
negative symptoms (Nesvåg et al. 2009; Lacerda et al. 2007; Volpe et al. 2012). Finally, 
disorganisation symptoms have been associated with brain morphological reductions in two 
studies (Lui et al. 2009; Molina et al. 2003), while two others found no association (Flaum et 
al. 1995; Zhang et al. 2014). 
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There are several possible explanations for these inconsistent findings. First, the phase of 
illness and extent of exposure to treatment may influence results, as brain volume, cortical 
thickness and symptoms change over time. Progressive brain volume reductions (Ho et al. 
2011) and cortical thinning (van Haren et al. 2008) have been reported, particularly in the 
early years of illness. These reductions have been associated with both illness progression 
(Ziermans et al. 2010) and medication exposure (Fusar-Poli et al. 2013). Indeed, it was for 
these reasons that we obtained the MRI scans at baseline, before initiation of study 
treatment. It is therefore possible that associations between symptom expression and brain 
volume and cortical thickness may become more apparent as the illness progresses. In this 
regard, it has been proposed that there may be processes such as inflammation that, in the 
early stages of illness, lead to structural enlargement through water retention (Padmanabhan 
et al. 2014).  However, counting against this is that findings in other first-episode samples are 
also inconsistent. Of five such studies, one study reported associations between brain 
structure reductions and positive symptoms only (Lui et al. 2009), another with negative 
symptoms and disorganised symptoms (Molina et al. 2003), another with negative symptoms 
only (Benoit et al. 2012), another found no associations (Fannon et al. 2000), and one study 
reported increased brain volumes associated with negative symptoms (Lacerda et al. 2007).  
 
Second, various methodological differences could explain the inconsistencies in findings to 
date. For example, most studies investigated specific rather than global brain regions, and 
these regions varied from study to study.  Different measures of brain structure (e.g. 
measures of cortical and subcortical volumes, cortical thickness, ventricular volumes) were 
also employed. In addition, different instruments were used to assess symptoms and patients 
were at various stages of treatment response. Finally, and most likely, our findings, together 
with those of most previous studies, suggest that brain morphology and symptom expression 
in schizophrenia are only weakly associated (Crespo-Facorro et al. 2009; Crespo-Facorro et 
al. 2007), and the neurobiological underpinnings of the clinical manifestations of illness may 
not be adequately captured by structural measures (Padmanabhan et al. 2014).  
 
Our failure to find an association between insight and brain measures could be explained by 
insight being related to regional rather than global brain structural deficits. Indeed, in a 
previous study of ours in a cohort overlapping that of the present study we found that 
symptom misattribution was associated with reduced left rostral middle frontal thickness and 
left anterior cingulate thickness specifically (Asmal et al. 2016).  A systematic review of 
neurobiological correlates of insight impairment in schizophrenia identified the prefrontal 
cortex, cingulate cortex, regions of the temporal and parietal lobe and hippocampus as 
possible neural correlates of insight (Xavier and Vorderstrasse 2016).  
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Limitations of our study include the relatively small sample and the limited study duration. 
Assessing changes in symptom expression and brain volumes over a longer period than 12 
months may yield different results. In addition, using endpoint scores as a measure of trait-
related features of the illness may not be entirely accurate, as factors such as medication 
side-effects and substance abuse may contribute to persistent symptoms.  
 
In conclusion, although significant associations between brain structure and symptom 
expression were few, the differential associations between state and trait related symptoms 
and brain structure indicate that future studies assessing the neurobiological underpinnings 
of the illness should take care to differentiate between state and trait related manifestations.  
 
 
 
 
 
Tables 
 
Table 1: Demographic and brain volume characteristics at baseline in FES patients (n=54)  
Variable   
Age in years (mean, SD) 24(5.8) 
Ethnic group (N, %)  
  mixed  45 (83) 
  black 5 (9) 
  white 4 (8) 
Male: female  2 
Highest school grade (mean, SD) 10 (2) 
DSM diagnosis (N, %)  
  Schizophrenia  36 
  Schizophreniform 18 
DUP days (mean, SD) 206 (222.2) 
Endpoint flupenthixol dose (mean, SD) 13(6.3) 
Global brain measures   
  Cortical volume, in mm3 (mean, SD) 444486 (52882.2) 
  White matter volume, in mm3 (mean, SD) 489154 (60011.0) 
  Subcortical gray matter volume, in mm3 (mean, SD) 187672 (15087) 
  Intracranial volume, in mm3 (mean, SD) 1394632 (182322.9) 
  Cortical thickness, in mm2 (mean, SD) 2.44 (0.13) 
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Table 2: Baseline and endpoint clinical and cognitive scores in FES patients (n=54) 
Variable Baseline score Endpoint score T p-value 
Mean  SD Mean SD   
NES       
Total 13 6.7 8 5.4 6.09 <0.001 
Sensory integration 2 2.2 1 1.8 3.80 <0.001 
Motor coordination 1 1.3 1 1.1 3.50 <0.001 
Motor sequencing 3 2.3 1 1.8 4.01 <0.001 
PANSS       
Total 93 15.9 47 12.9 20.89 <0.001 
Positive 13 2.9 4 2.4 16.48 <0.001 
Negative 17 4.6 10 4.0 11.6 <0.001 
Excitement/hostility 8 3.9 5 1.4 6.79 <0.001 
Disorganised 18 4.2 9 3.4 18.77 <0.001 
Depression/anxiety 9 4.3 6 2.6 6.73 <0.001 
CDSS total 4 4.3 2 3.1 3.59 <0.001 
SOFAS 45 12.7 65 12.4 -12.18 <0.001 
BIS       
Total 8 5.4 6 2.1 -0.10 0.54 
Symptom attribution 2 1.0 2 1.1 0.30 0.38 
Illness awareness 2 1.3 2 1.3 0.27 0.39 
Need for treatment 2 1.0 2 1.0 -0.87 0.81 
MCCB       
Processing speed 22 16.3 30 16.3 -4.77 <0.001 
Attention and vigilance 28 11.9 38 9.3 -5.50 <0.001 
Working memory 27 16.2 36 12.8   
Reasoning and problem solving 33 9.6 40 11 -4.82 <0.001 
Verbal learning 35 9.3 39 8.6 -2.80 0.003 
Visual learning 33 15.9 40 13.6 -3.47 <0.001 
Social cognition 28 12.8 40 11.0 -1.74 0.04 
Composite score 17 15.4 27 15.1 -5.86 <0.001 
 
NES, Neurological Evaluation Scale; PANSS, Positive and Negative Syndrome Scale; 
CDSS, 
Calgary Depression Scale for Schizophrenia; SOFAS, Social and Occupational Functioning 
Assessment Scale; MCCB, MATRICS Consensus Cognitive Battery. 
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Table 3: Hierarchical regression analysis for predictors of brain volumetric measures in 
schizophrenia patients (n=54) 
Model Change score Endpoint score 
 R2 ∆ F P R2 ∆ F  P 
Cortical Volume       
ICVa 0.41 36.3 <0.001* 0.41 36.3 <0.001* 
ICV + Demographicb 0.52 3.58 0.02* 0.52 3.59 0.02* 
ICV + Demographic + Clinicalc 0.52 0.37 0.55 0.54 2.08 0.16 
ICV + Demographic + Clinical + Cognitived 0.63 2.49 0.04* 0.67 6.19 0.001* 
White matter volume       
ICV 0.37 30.1 <0.001* 0.37 30.1 <0.001* 
ICV + Demographic 0.54 6.15 0.001* 0.54 6.15 0.001* 
ICV + Demographic + Clinical  0.62 4.62 0.02* 0.58 2.46 0.09 
  ICV + Demographic + Clinical + Cognitive 0.64 1.11 0.35 0.06 1.23 0.31 
Subcortical Volume       
ICV 0.18 11.5 0.001* 0.18 11.5 0.001* 
ICV + Demographic 0.25 1.45 0.24 0.25 1.45 0.24 
ICV + Demographic + Clinical 0.25 0.05 0.82 0.32 5.37 0.02* 
ICV + Demographic + Clinical + Cognitive 0.30 1.86 0.17 0.47 3.11 0.02* 
Cortical Thickness       
Demographic 0.02 0.33 0.80 0.02 0.33 0.80 
Demographic + Clinical N/A   0.09 4.90 0.03* 
Demographic + Clinical + Cognitive N/A   N/A   
 
a ICV= intracranial volume. Cortical thickness not adjusted for ICV 
b Age, sex, highest level of education achieved. 
c Clinical factors significant on correlation analysis i.e. For change scores: white matter 
volume: motor coordination, sensory integration; cortical volume: total insight; subcortical 
gray: total insight; cortical thickness: nil. For endpoint scores: white matter volume: symptom 
awareness, sensory integration; cortical volume: symptom awareness, sensory integration; 
subcortical gray matter volume: sensory integration; cortical thickness: social and 
occupational functioning. 
d Cognitive factors significant on correlation analyses i.e. For change scores: white matter 
volume: processing speed, visual learning, social cognition; cortical volume: processing 
speed, verbal learning, visual learning, social cognition, working memory; subcortical gray: 
processing speed, social cognition; cortical thickness: nil. For endpoint scores: white matter 
volume: reasoning and problem solving, processing speed, working memory, verbal learning, 
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visual learning, social cognition; cortical gray: working memory, verbal learning; subcortical 
gray: processing speed, working memory, social cognition, verbal learning; cortical thickness: 
nil.  
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Supplementary Table 1: Correlations between brain volume at baseline and clinical and 
cognitive change scores (state relationships) 
Endpoint variables  
log cortical volume log white matter 
volume 
log subcortical gray 
volume 
Global 
Cortical 
thickness  
r2 P r2 P r2 P r2 P 
NES         
Total -.223 p=.113 -.199 p=.157 -.122 p=.389 -0.060 0.665 
Sensory integration -.323 p=.019** -.340 p=.014** -.238 p=0.09* -0.079 0.570 
Motor coordination -.078 p=.581 -.132 p=.350 -.023 p=.873 0.027 0.845 
Motor sequencing -.181 p=.198 -.207 p=.141 -.187 p=.183 -0.030 0.830 
MCCB         
Processing speed .136 p=.337 .298 p=.032** .283 p=.042** -0.160 0.248 
Attention and 
vigilance 
.061 p=.665 .020 p=.887 .058 p=.685 
0.070 0.618 
Working memory .314 p=.023** .381 p=.005** .273 p=.050* -0.044 0.618 
Verbal learning .314 p=.023** .314 p=.024** .325 p=.019** -0.750 0.590 
Visual learning .193 p=.171 .268 p=.054* .190 p=.179 0.136 0.352 
RPS .174 p=.216 .236 p=.092* .105 p=.460 0.136 0.352 
Social cognition .182 p=.197 .370 p=.007** .401 p=.003** -0.213 0.122 
PANSS         
Total -.151 p=.284 -.090 p=.524 -.001 p=.998 -0.265 0.230 
Positive -.086 p=.546 -.087 p=.540 -.036 p=.800 -0.031 0.840 
Negative -.016 p=.910 .051 p=.721 .090 p=.525 -0.092 0.507 
Excitement/hostility -.118 p=.406 -.095 p=.501 -.104 p=.462 -0.175 0.397 
Disorganised -.215 p=.126 -.188 p=.183 -.123 p=.384 -0.216 0.117 
Depression/anxiety -.192 p=.173 -.156 p=.267 -.064 p=.652 -0.092 0.507 
SOFAS .066 p=.642 -.126 p=.374 -.176 p=.211 0.270 0.048* 
CGI -.031 p=.827 -.019 p=.893 .176 p=.212 -0.099 0.476 
CDSS -.133 p=.349 -.157 p=.267 -.068 p=.632 -0.040 0.773 
BIS         
Total -.156 p=.268 -.248 p=.076* -.107 p=.451 -0.165 0.230 
Symptom 
attribution 
-.047 p=.743 -.011 p=.938 -.139 p=.324 
0.028 0.838 
Illness awareness -.268 p=.055* -.295 p=.034** -.144 p=.308 0.075 0.588 
Need for treatment .076 p=.593 -.155 p=.274 .111 p=.434 0.086 0.535 
 
NES, Neurological Evaluation Scale; PANSS, Positive and Negative Syndrome Scale; CDSS 
Calgary Depression Scale for Schizophrenia; SOFAS, Social and Occupational Functioning 
Assessment Scale; MCCB, MATRICS Consensus Cognitive Battery. 
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* uncorrected p-value statistically significant at <0.05 
** uncorrected p-value<0.1 qualifying for entry into regression model 
 
 
Supplementary Table 2: Correlations between brain volume at baseline and clinical and 
cognitive endpoint scores (trait relationships) 
Endpoint variables  
log cortical 
volume 
log white matter 
volume 
log subcortical gray 
volume 
Global 
Cortical 
thickness  
r2 P r2 P r2 P r2 P 
NES         
Total -.223 p=.113 -.199 p=.157 -.1219 p=.389 -0.060 0.665 
Sensory integration -.323 p=.019** -.340 p=.014** -.238 p=0.09* -0.079 0.570 
Motor coordination -.078 p=.581 -.132 p=.350 -.023 p=.873 0.027 0.845 
Motor sequencing -.181 p=.198 -.207 p=.141 -.187 p=.183 -0.030 0.830 
MCCB         
Processing speed .136 p=.337 .298 p=.032** .283 p=.042** -0.160 0.248 
Attention and 
vigilance 
.061 p=.665 .020 p=.887 .058 p=.685 
0.070 0.618 
Working memory .314 p=.023** .381 p=.005** .273 p=.050* -0.044 0.618 
Verbal learning .314 p=.023** .314 p=.024** .325 p=.019** -0.750 0.590 
Visual learning .193 p=.171 .268 p=.054* .190 p=.179 0.136 0.352 
RPS .174 p=.216 .236 p=.092* .105 p=.460 0.136 0.352 
Social cognition .182 p=.197 .370 p=.007** .401 p=.003** -0.213 0.122 
PANSS         
Total -.151 p=.284 -.090 p=.524 -.001 p=.998 -0.265 0.230 
Positive -.086 p=.546 -.087 p=.540 -.036 p=.800 -0.031 0.840 
Negative -.016 p=.910 .051 p=.721 .090 p=.525 -0.092 0.507 
Excitement/hostility -.118 p=.406 -.095 p=.501 -.104 p=.462 -0.175 0.397 
Disorganised -.215 p=.126 -.188 p=.183 -.123 p=.384 -0.216 0.117 
Depression/anxiety -.192 p=.173 -.156 p=.267 -.064 p=.652 -0.092 0.507 
SOFAS .066 p=.642 -.126 p=.374 -.176 p=.211 0.270 0.048* 
CGI -.031 p=.827 -.019 p=.893 .176 p=.212 -0.099 0.476 
CDSS -.133 p=.349 -.157 p=.267 -.068 p=.632 -0.040 0.773 
BIS         
Total -.156 p=.268 -.248 p=.076* -.107 p=.451 -0.165 0.230 
Symptom attribution -.047 p=.743 -.011 p=.938 -.139 p=.324 0.028 0.838 
Illness awareness -.268 p=.055* -.295 p=.034** -.144 p=.308 0.075 0.588 
Need for treatment .076 p=.593 -.155 p=.274 .111 p=.434 0.086 0.535 
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NES, Neurological Evaluation Scale; PANSS, Positive and Negative Syndrome Scale; 
CDSS, Calgary Depression Scale for Schizophrenia; SOFAS, Social and Occupational 
Functioning 
Assessment Scale; MCCB, MATRICS Consensus Cognitive Battery. 
* uncorrected p-value statistically significant at <0.05 
** uncorrected p-value<0.1 qualifying for entry into regression model 
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This chapter synthesises the findings of the included journal manuscripts, summarizes 
contributions to existing knowledge, and ends with a section on future research directions. 
The PhD comprises five journal articles each asking distinct neuroimaging research 
questions that are connected in terms of clinical relevance at a local and international level.  
 
The focus of Chapter 2 and 3 is on brain deficits associated with impaired insight in FES. 
Impaired insight is a highly prevalent feature of schizophrenia that is associated with poorer 
outcome (Margariti et al. 2015; Yalcin-Siedentopf et al. 2014; Johnson et al. 2012; Amador et 
al. 1994). Poor treatment adherence and the related issue of diminished insight in 
schizophrenia was fundamental to the study design of the parent study where we combined 
the lowest effective dose of flupenthixol decanoate medication with an assertive monitoring 
program (Chiliza et al. 2016). For my PhD, we examined the relationship between insight, as 
measured by the Birchwood Insight Scale (BIS) (Birchwood et al. 1994), and brain deficits 
using two neuroimaging modalities, namely diffusion tensor imaging (chapter 2) and cortical 
thickness (chapter 3). 
 
In Chapter 2, we examined for an association between white matter fractional anisotropy and 
clinical insight in 89 FES patients. Looking at other neuroimaging studies, evidence for clear 
patterns in relation to insight in schizophrenia is limited. This might be because insight is a 
nuanced, multifaceted concept and may fractionate across clinical and cognitive dimensions 
into a number of domains (David et al. 2012). Indeed, we found that the white matter neural 
signature of total insight was widespread and predicted by a complex network of tracts. On 
the other hand, we found that the network of tracts that predicted the domains of ‘illness 
awareness’ and ‘need for treatment’ were separable, and that FA values did not predict the 
‘symptom attribution’ domain.  
Shad and Keshavan (Shad and Keshavan 2015) hypothesised that fewer and more specific 
frontal areas may be involved in symptom misattribution, possibly due to a failure to recruit 
compensatory brain mechanisms.  We therefore extended their theory in Chapter 3 by 
specifically examining the relationship between symptom attribution and frontal cortical 
thickness in 92 FES patients. Symptom misattribution was associated with significantly 
thinner left anterior cingulate and left rostral middle frontal cortices.  Symptom attribution, 
which involves the patient’s ability to relabel the signs and symptoms of schizophrenia as 
pathological, is thought to require a higher level of insight functioning than the other clinical 
insight domains, in that it involves the ability to monitor and control ongoing mental activities 
(David et al. 2012). The rostral middle frontal region is akin to the dorsolateral prefrontal 
cortex and plays an important role in executive function, concept flexibility and self-
monitoring. These functions are central to the ability to properly recognize, interpret and 
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relabel symptoms and signs (Morgan et al. 2010). Also in keeping with the metacognitive 
nature of symptom attribution (David et al. 2012), the anterior cingulate has been found to 
play a key role in the aberrant attribution of salience to stimuli in schizophrenia 
(Palaniyappan and Liddle 2012), and as a result may contribute to the incorrect attribution of 
symptoms in the illness.  
An additional finding from our neuroimaging insight studies is that patients who were more 
depressed had significantly greater total insight, increased recognition of the need for 
treatment and increased illness awareness (detailed in Chapter 2). Meta-analyses of studies 
examining the relationship between depression and insight corroborate these findings (Murri 
et al. 2015; Mintz et al. 2003). We did not find a relationship between insight and positive and 
negative symptomatology which is unsurprising given that results from other studies are 
inconsistent and correlations when found are at best modest (Mintz et al. 2003). A recent 
commentary recommended that future research in the neurobiology of insight in 
schizophrenia should be in larger samples in the early phase of the illness to avoid the 
confounding effects of medication and illness chronicity, and should address different 
dimensions of insight (Shad 2017).  Our studies go some way in addressing this need. Our 
team is now in the process of analysing the longitudinal insight data from the parent study.  
Also, in the next cohort of schizophrenia patients that we recruited, we included an 
assessment of cognitive insight.   
 
As a first step in the methodology of the DTI insight journal article in Chapter 2, we examined 
for FA differences between 89 FES patients and 98 matched healthy controls. We found 
widespread reduction in FA in FES patients compared to controls and our subgroup analysis 
found no difference in FA between minimally treated and treatment naïve patients, but clear 
differences between patients and controls. DTI findings in FES are variable (Wheeler and 
Voineskos 2014). At the time of manuscript publication, this was the largest known DTI 
cohort of FES patients. Again, the main advantages of our cohort are the large sample size 
in a difficult to recruit population, and the ruling out of long-term medication and chronicity as 
far as possible as confounds. Our findings therefore lend considerable support to the theory 
that white matter changes in schizophrenia are an intrinsic marker of the disorder (Haijma et 
al. 2012), and appear to be linked to the neurodevelopmental model of the illness (Sommer 
and Kahn 2014; Collin et al. 2013).  
 
There is growing evidence that childhood and adolescence are sensitive stress exposure 
periods when structures and pathways impacted by trauma are most vulnerable. This can 
result in an alteration in trajectories of brain development and childhood trauma is a risk 
factor for schizophrenia. Given that levels of childhood trauma are higher in Low and Middle-
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Income Countries (LMICs) compared to High Income Countries (Viola et al. 2016), it is 
especially important that LMICs are at the forefront of childhood trauma research. We have 
reported in an earlier study, that the rates of childhood trauma in both patients and controls in 
our cohort were considerably higher than those reported in other studies (Kilian et al. 2017). 
Given this concerning finding and its possible impact on neurodevelopment, we examined 
the relationship between childhood trauma and FA in 53 FES patients and 51 controls. Our 
findings highlight altered cortico-limbic circuitry in FES patients compared to controls and 
differential effects of childhood emotional neglect (increased FA) and sexual abuse 
(decreased FA) on white matter in patients. To our knowledge, at the time of journal 
manuscript submission for publication, this was the first study examining the relationship 
between childhood trauma, FA and FES.  
 
Examining for neuroimaging predictors of symptom expression in FES studies has been met 
with limited success.  In Chapter 5, we carefully investigated the relationship between broad 
neuroimaging measures (global cortical thickness and global cortical, subcortical and white 
matter volume) and a wide range of trait and state clinical and cognitive symptoms. Our 
results suggest a differential association between state and trait symptom expression and 
global brain measures, in that baseline subcortical gray matter volume was significantly 
associated with sensory integration and verbal learning trait scores, cortical volume with 
verbal learning trait scores, cortical thickness with social and occupational functioning trait 
scores, and white matter volume with motor coordination state scores. Of particular potential 
relevance to patient care, is that these neuroimaging deficits noted at initial presentation in 
FES, may predict enduring trait deficits in cognition, functioning and neurological soft signs.  
 
In Chapter 6, we found substantial cortical brain volume reductions over twelve months of 
treatment in antipsychotic naïve patients compared to matched controls.  Total antipsychotic 
dose was a predictor of this reduction in patients however cortical reduction occurred at even 
the lowest effective antipsychotic dose and unrelated to treatment related side effects or 
treatment outcome. Although previous longitudinal neuroimaging studies have described 
progressive reduction in brain volume in schizophrenia (Liberg et al. 2016; Hulshoff Pol and 
Kahn 2008; Pantelis et al. 2005), and that these progressive changes may at least in part be 
due to antipsychotic treatment (Vita et al. 2015; Lieberman et al. 2005), most prior studies 
were retrospective and antipsychotic medication type, dose and adherence was not 
systematically assessed. In our study, all patients were on a single antipsychotic type and 
the depot formulation ensured that dose received and adherence was known. Our study 
contributes significantly to this knowledge field in that our finding of a significant relationship 
between antipsychotic dose and cortical volume reduction in this study strongly suggests 
causality.  
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LOCALLY AND GLOBALLY RELEVANT FUTURE RESEARCH DIRECTIONS 
Clinically nested neuroimaging research is dependent on the validity of the available clinical 
data.  Therefore, for the next phase of our study, we have strengthened our assessment of 
‘insight’ by including an assessment of cognitive insight (Beck et al. 2004). Further, our 
schizophrenia team was recently trained by Prof Helen Fisher, an expert in childhood 
trauma, in the Childhood Experience of Care and Abuse Interview (CECA) a comprehensive 
structured narrative interview that assesses childhood trauma retrospectively (Bifulco et al. 
2005). Prof Paola Dazzan also hosted a workshop on clinical outcomes in schizophrenia and 
the clinical utility of neuroimaging in psychotic disorders. Both researchers are from the 
Institute of Psychiatry, Psychology and Neuroscience, King’s College London and we hope to 
develop this collaboration further.  
 
Two papers in this PHD are related to DTI. The focus has shifted internationally and is 
evolving in our own unit towards investigating connections across and within networks rather 
than exclusively examining DTI measures along discrete pathways (Collin et al. 2016). There 
is increasing evidence that the manifestations of schizophrenia are not solely related to 
disturbances of individual brain regions but emerge from their interaction within local 
networks as well as within multiple, large-scale neural systems (Narr and Leaver 2015). 
Members of our neuroimaging team are currently being trained in connectomics and the 
related advanced computational analysis with a particular focus on the clinical utility of the 
connectome.  We hope to look at childhood trauma and its relationship to the connectome in 
schizophrenia and healthy controls as a potential study.   
 
This PhD highlighted frequent inconsistencies in neuroimaging studies and one potential 
reason for these inconsistencies is that single modality studies may only partially detect 
neurobiological deficits (Sui et al. 2012). We have functional data available on a subset of 
patients and a possible next step for our research is a multi-modality study approach, for 
example using resting state functional MRI and DTI to describe whole brain differences in 
functional and structural connectivity and the relationship with specific symptom dimensions.  
 
Advances in automated MRI tools have also recently included a hippocampal subfield 
segmentation package (Fischl 2012). At this point, manual tracing remains the gold standard 
(Wisse et al. 2014), however it is a labour intensive process, and automated segmentation is 
a useful way for us to look at hippocampal subfields and the hippocampal-amygdala complex 
that are important in both schizophrenia (Ho et al. 2017) and childhood trauma (Teicher et al. 
2016).  
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Finally, I along with other members of our neuroimaging team, recently joined the ENIGMA 
(Enhancing Neuroimaging Genetics through Meta-analysis) consortium, a network that 
brings together researchers in imaging genetics for large collaborative neuroimaging projects 
(Thompson et al. 2014). One of the limitations of neuroimaging studies relate to small sample 
sizes and although inter-site discrepancies need to be considered, large collaborations that 
include low and middle-income countries are important.  
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